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SUMMARY 
Existing evidence suggests that hypertension is 
linked to a high dietary sodium intake, but the precise 
pa thophys iologic mechanism is not known. It has been 
proposed that the increase in blood pressure is the result 
of inhibition of vascular Na + , K+ -ATPase by a Circulating 
digoxin-like natriuretic hormone. This hormone is 
released in response to extracellular fluid volume 
expansion, and its presence has been demonstrated in salt-
loaded rats. Recent studies suggest that chronic 
inhibition of Na+ ,K+-ATPase may result in adaptive 
regeneration of the pump activity, but little is known 
about this in the vascular tissue. The present study is 
undertaken to examine the consequences of acute and 
chronic inhibition of Na+,K+-ATPase in various tissues by 
exogenous digoxin and endogenous natriuretic hormone in 
the rat. 
The digoxin regimes consisted of daily oral 
administration of digoxin for 3 days, 7 days and 3 months. 
The putative natriuretic hormone was induced by salt 
loading. Rats were salt-loaded for 7 days, 3 months and 
over one year. At the end of the treatment periods, crude 
homogenates of the heart, liver, skeletal muscle, kidney 
and aorta were prepared and treated with deoxycholate. A 
kinetic fluorimetric 3-0-methylfluorescein phosphatase 
11 
assay was developed to measure the vascular Na+,K+-ATPa se 
activity. A coupled-enzyme assay was used to determine 
the Na+,K+-ATPase activity in other tissues. 
It was found that in rats treated with digoxin for 3 
and 7 days, there was inhibition of the sodium pump in all 
the tissues studied. Upon chronic digoxin treatment for 3 
months, the Na+,K+-ATPase activity of all the tissues 
except that of the vascular tissue returned to the 
control values. This indicates that the inhibitory effect 
of digoxin does not persist. However, the vascular Na + K+-, 
ATPase activity remained inhibited after 3 months of digoxin 
treatment. 
In the 7-day and 3-month salt loading exp'eriments, 
the Na+,K+-ATPase activity of the heart, skeletal muscle 
and vascular tissue was not significantly different from 
the control values. The Na+,K+-ATPase activity of the 
renal medulla was significantly increased after 7 days of 
salt loading. Elevation of the hepatic Na+,K+-ATPase 
activity was observed after 3 months of salt loading. 
Salt loading for one year, however, resul ted in a 
significant increase in the Na+,K+-ATPase of all the 
tissues studied compared to control rats. 
These results demonstrate that the inhibition of 
Na+,K+-ATPase activity by digoxin and the putative 
natriuretic hormone does not persist and there is an 
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CHAPTER 1 INTRODUCTION 
Hypertension 
community problem 
(HT) is an increasingly significant 
throughout the world. If the WHO 
definition of hypertension (1978) is used, then almost 20% 
of adult population and as high as 70% of the elderly are 
hypertensive in affluent societies (Norman & Kaplan 1983; 
Kaplan 1986). In Hong Kong, the prevalence of HT has been 
reported to be 15% and the mortality rate from 
hypertensive diseases is rising (Woo et al 1981). The 
high risk of cardiovascular diseases and the 
complications (e.g. renal failure) associated with HT have 
prompted diligent attempt worldwide to elucidate the 
pathogenesis of hypertension so that prevention or 
effective therapy could be instituted. 
The cause of HT in most patients (up to 95%) remains 
unknown and is referred to as essential or primary HT. 
According to Page's multifaceted mosaic theory of blood . 
pressure control · (Page ' '.& ' "Coreoran 1949) I there is no 
single defect that starts the haemodynamic cascade towards 
HT. The general view is tha t HT is due to the 
interaction of a number of environmental factors in those 
with genetic susceptibility (Dahl et al 1962; Editorial, 
Lancet 1983). The evidence for the importance of heredity 
in HT comes from the observation that HT tends to run in 
families and it is more common in some races e.g. blacks 
in North America (Luft et al 1979a,bi Rowland & Roberts 
1 
1982). Of the environmental factors, dietary s odium int a k e 
is an important one and there is a great d ea l of 
experimental and epidemiological evidence linking e x c ess 
dietary sodium intake to the development of HT. (Section 
2.1. page 4) 
The mechanism(s) by which dietary sodium exerts its 
pathogenic role is not clearly understood. Studies over 
the past 25 years have linked dietary salt intake and 
cellular sodium transport activity mediated by sodium, 
potassium-activated ATPase (Na+,K+-ATPase, E.C. 
3.6.3.37.). 
High salt intake causes expansion of the 
extracellular fluid volume and the release of several 
natriuretic factors such as atrial natriuretic - peptides 
(ANP) , dopamine and natriuretic hormone (NH). It has been 
proposed that in susceptible individuals there is an 
intrinsic defect in renal sodium excretion (Guy ton et al 
1972; Haddy & Overbeck 1976). The failure to excrete 
sodium causes increased release of the natriuret i c hormone 
(NH) which is a Na+,K+-ATPase inhibitor. The NH inhibits 
renal Na+,K+-ATPase causing natriuresis and restoring 
sodium balance. In addition to the inhibition of the 
renal Na + , K+ -ATPase, the NH also inhibi ts the vascular 
Na+ ,K+-ATPase activity leading to enhanced vascular 
contractility resulting in elevated total peripheral 
resistance (Overbeck et al 1976; Blaustein 1977). 
2 
This hypothesis is very attractive. However, the 
endogenous NH has not been isolated or fully characteri sed 
and the regulation of vascular Na+,K+-ATPase has not been 
extensively studied. There is insufficient and discrepant 
data on the activity of the vascular sodium pump in 
volume-expanded models of HT. Furthermore, the elevation 
of blood pressure in hypertension is long-standing and 
this implies that the inhibi tion of vascular Na+ K+-, 
ATPase, if any, must be sustained. Experimental evidence 
has shown that when the Na+,K+-ATPase is inhibited, there 
is a compensatory increase in enzyme activity due to an 
adaptive response of pump sites (Lindsay & Parker 1976; 
Bonn & Greeff 1978; Lechene 1988). In the present study, 
the time-related changes in tissue and vascular Na+,K+-
ATPase in the presence of endog~nous and exogenous 
inhibitors of Na+,K+-ATPase were measured. The objective 
is to clarify the pathophysiological significance of NH in 
the salt- or volume-dependent form of HT. 
3 
CHAPTER 2 LITERATURE REVIEW SALT AND HYPERTENSION 
2.1. Summary of evidence linking salt and hypertension 
The role of sodium in HT has long been recognised 
since the time when the potential health hazards of a high 
sodium intake were mentioned in the Yellow Emperor's 
Classics of Medicine in 2600 B. C. Recently, the role of 
dietary sodium intake as a possible initiating factor has 
been emphasised by epidemiological studies, clinical 
trials of dietary sodium manipulation and experimental 
studies. 
2.1.1. Epidemiological studies 
Epidemiological studies have shown that there is a 
positive correlation between dietary salt intake and the 
prevalence of HT across different populations (Dahl 1961; 
Gleibermann 1973; Sinnett & Whyte 1973; Oliver et al 1975; 
Tobian 1979). For instance I the blood pressure of 27 
communities was found to be related to the average salt 
intake (Gleibermann 1973). Primitive unaculturated people 
such as the Yanomamo Indians and New Guineans who eat 
little sodium do not have HT, and there is very little 
rise in blood pressure wi th age in these people (Freis 
1976; Oliver et al 1975). Cross-cultural studies have 
shown that in populations who have a sodium intake below 
30 mmol/day, almost no HT is found (Tobian 1979). When 
4 
the sodium intake is 
incidence of HT rises 
between 30-60 mmo l / day, th e 
but remains below 3%. vlhen the 
sodium intake is 150 mmol/day and over, the incidence of 
HT is found to be 10% or higher (Page et al 1974). 
Meneely and Battarbee (1976) and Trowell (1980) pointed 
out that the current high sodium intake is such a recent 
phenomenon that genetic adaptation has not been possible . 
Our herbivorous ancestors probably consumed far less 
sodium per day (Eaton & Konner 1985). 
In contrast to between-population studies, studies 
wi thin a s ingle population has produced conf licting 
results (Cooper et al 1980; Khaw 1983; Simpson et al 
1978). Cooper et al (1980) studied 73 schoolchildren and 
reported a significant correlation (r=0 . 386, p ~ O . OOl) 
between the mean sodium intake (estimated from seven 
consecutive 24-hour urine samples) and blood pressure . 
Khaw (1983) also found a significant correlation between 
systolic blood pressure and urinary sodium/creatinine 
rati"o in 93 factory workers (r=0 . 25, p<O.OS). However, 
Simpson et al (1978) failed to document a significant 
relationship between mean blood pressure and sodium intake 
(estimated from a single 24 - hour urine sample) in over 
1,000 New Zealanders (mean age=40). Kesteloot et al 
(1980) demonstrated a direct relationship between urinary 
sodium excretion and blood pressure in 450 individuals in 
Korea (mean age=35) but not in 300 individuals (mean 
age=39) in Belgium. 
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These discrepancies could be due to methodological 
problems and/or to other confounding variables such as 
climate, level of acculturation, physical activity, body 
mass index, alcohol intake. These confounding variables 
differ widely across centres but less so within centres. 
Methodological problems include inadequate sample size, a 
fairly narrow range of sodium intake, and the difficulty 
of assessing an individual's sodium intake reliably 
without resorting to multiple urine collections. 
The fact that only about 20% of the Western 
population will develop hypertension suggests a 
heterogeneity of sodium sensitivity. To demonstrate a 
relationship between sodium intake and blood pressure, a 
relatively large sample size is required. 
In 1982, an international collaborative study called 
INTERSALT STUDY was initiated. In this study, 
standardised methods were applied and sufficient numbers 
of subjects in varied populations were included to 
eliminate the methodological problems discussed above. 
Over 10,000 subjects from 52 centres were studied. It was 
found that the systolic blood pressure was significantly 
related to the sodium intake of individuals. (Rose & 
Stamler 1989). In within-centre analyses of the 
regression coefficients for sodium intake and blood 
pressure, adjustments were made for the effect of sex and 
age. With this type of analysis, a positive association 
6 
b e tween dietary sodium intake and blood pressure was foun d 
in 39 out of the 52 centres. When the 52 c e n t r es were 
pooled, the combined regression coefficient was O. 016 3mm 
Hg/mmol Na(p<O.OOl). 
In cross-centre analysis, a significant linear 
relationship was found between sodium intake and the rise 
in blood pressure with age. The regression coefficient 
was 0.003 mm Hg year- 1 mmol- 1 Na (p<O.OOl). The sodium 
intake and prevalence of hypertension were also positively 
and significantly related (r=0.0477%/mmol Na (p=O.Ol) to 
b = 0 . 0 6 2 5 % / mm 0 1 N a ( p = 0 . 0 1 ) ) . There · were two main 
conclusions from this large study regarding sodium and 
blood pressure. The blood pressure was significantly 
related to sodium intake although the relationship was 
weaker than that between blood pressure and -some other 
factors (e.g. alcohol, body mass index). The within-
centre slope of rise in blood pressure with age was 
significantly related to mean sodium intake for the 
systolic blood pressure. 
The evidence discussed above is circumstantial and 
many other factors (e. g. socioeconomic factors, life 
style, level of acculturation) may also be involved. 
2.1.2. Dietary intervention studies 
Further supporting evidence for the association of 
sodium and HT comes from dietary intervention studies, 
7 
i.e. dietary sodium manipulation in the treatment o f HT. 
Ambard and Beaujard (1904) were the pioneer g r o up to 
report that salt restriction may be associated with a 
decline in blood pressure in hypertensive subjects. This 
was later substantiated by the work of Alien and Sherrill 
(1922) . In his classical experiment I Kempner (1948) 
successfully reversed malignant HT in 66% of patients 
on a rice-fruit diet containing less than 8mmol of sodium 
per day. In an open controlled trial in 31 hypertensive 
patients (Morgan et al 1978) I salt restriction alone 
reduced the diastolic pressure as effectively as thiazides 
and/or f3-blockers. Parijs et al (1973) studied 22 
patients with an initial diastolic pressure of 115 mrnHg 
and showed that sodium restriction from 191 to 93 mmol/day 
reduced the blood pressure by an average of 7.7/4.4 mrnHg. 
Several other studies have confirmed that sodium 
restriction causes a reduction of blood pressure in 
hypertensive subjects (Murphy 1950; Morgan et al 1978; 
MacGregor et al 1982). On the other hand, Watt et al 
(1983) and Silman et al (1983) failed to find a 
significant reduction in blood pressure when salt intake 
was reduced (from 143 mrnol/day to 87 mrnol/day for 4 weeks 
in the study of Watt et al (1983) and 150 mrnol/day to 117 
rnrnol/day for 12 months in the study of Silman et al 
(1983)). Nicholls et al (1984) also found no significant 
change in the blood pressure of 12 patients during dietary 
sodium restriction (from 210 to 100 nmol/day) for 35 days. 
8 
Diuretics are the most commonly used drugs in the 
treatment of HT (Woo et al 1985). They increase the 
excretion of sodium via the kidney and reduce the ECF 
volume resulting in a fall in blood pressure. This 
natriuretic and antihypertensive effect has long been 
documented (Wilson & Freis 1959; Bowman & Rand 1980). 
Parijs et al (1973) showed that diuretics plus sodium 




blood pressure in patients with mild 
The clinical efficacy of diuretics in HT 
support for the role of salt in the 
pathogenesis of HT. 
2.1.3. Experimental studies 
Animal experiments further substantiated the 
relationship between sodium and blood pressure. HT can be 
induced by excessive sodium intake in animals such as 
dogs, chicken~ and rats (Lenal et al 1948; Sapirstein et 
al ·1950). Such sodium-induced HT occurs more readily when 
there is a reduction of renal mass (e.g. uninephrectomy) 
or impaired renal function (Seyrnour et al 1980). In the 
classical experiment of Meneely and Ball (1958), systolic 
blood pressure was shown to have a linear correlation with 
the average daily salt intake in rats. Grollman and 
Grollman (1962) demonstrated that increasing the salt 
intake in pregnant rats resulted in higher blood pressure 
in the offsprings. The rise in blood pressure in 
9 
deoxycorticosterone-induced HT can be prevented by a low 
salt intake (Berecek et al 1980). Dahl and associates 
(1962) bred 2 strains of rats that mimicked hypertension 
in man. When these strains were challenged with high 
dietary salt, one strain (salt-sensitive) gradually became 
hypertensive while the other (salt-resistant) remained 
normotensive. The observation carries significant 
implication, i. e. excessive dietary salt intake induces 
hypertension in those who are genetically salt-sensitive. 
In conclusion, there is substantial evidence linking 
dietary sodium intake and HT. Sodium is involved in the 
pathogenesis of HT in certain subgroups (namely those who 
are salt-sensitive) of the population. 
2.2. Cellular sodium transport 
2.2.1. The Sodium Pump 
In order to understand the relationship between 
sodium and hypertension, workers have focussed their study 
on the sodium transport across the cell membrane. 
As illustrated in Fig. 2.1., there are at least four 
cellular sodium transport mechanisms, among which the 
active, electrogenic sodium pump is the major transport 
process. Discovered by Skou in crab nerve microsome in 
1957, the sodium pump is an intrinsic membrane enzyme 










































































































































































































sodium and potassium ions in all living animal cells. The 
pump is activated by intracellular magnesium (obligatory), 
ATP and sodium, and extracellular potassium ions. Na+,K+-
stimulated Mg++-dependent adenosine triphosphatase 
+ + ) (Na ,K -ATPase, E.C. 3.6.1.3. is the enzymatic expression 
of the sodium pump. The sodium pump is ubiquitous and it 
performs many important functions. The generation of a 
concentration gradient for each ion across the plasma 
membrane is important for the maintenance of cell volume, 
excitability of nerves and muscles, intestinal absorptive 
and renal reabsorptive processes, and active transport of 
molecules such as glucose. The enzyme is present in most 
animal cells and is found in large quantities in organs 
such as the brain and kidney (Bonting 1970; Glynn & 
Karlish 1975). 
Based on the Post-Albers model (Post et al 1969; 
Albers et al 1968), the enzyme is postulated to exist in 
two conf igurations, namely, the dephosphorylated native 
form with high Na affinity and the phosphorylated form 
bearing an outward specific K-binding site (Fig. 2.2.). 
Studies on purified Na+,K+-ATPase showed that it consists 
of two polypeptide subunits alpha and beta subuni ts . 
The larger alpha subunit is the catalytically active site 
for ATP hydrolysis and binding sites for cardiac 
glycosides (Jorgensen et al 1973; Rouho & Kyte 1974; Skou 
1988). The smaller beta subunit is functionally inactive. 
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structure of Na+,K+-ATPase to be (a,B)2-
Based on the difference in gel mobility and 
sensitivity to digitalis, Sweadner (1979) demonstrated 
that there is a heterogeneity of the subunit of Na+,K+-
ATPase in different tissues _ Bereebi-Bertrand and 
coworkers (1988) compared the properties of a isoforms 
(i _ e. a and a+) present in rat brain and heart. They 
showed that there was tissue specificity of the alpha plus 
isoform. The Na+,K+-ATPases from the brain and the heart 
differ in their sensitivity to ouabain. 
ATP. 
Na+,K+-ATPase catalyses the sequential hydrolysis of 
Three Na + ions are moved out and two K+ ions are 
taken up by the cell for each molecule of ATP hydrolysed 
(Baker et al 1969). Digitalis and other cardiac 
glycosides are specific inhibitors of this enzyme (Post et 
al 1960; Skou 1960). Ouabain I a cardiac glycoside, is 
frequently used in the measurement of the enzyme activity. 
2.2.2. Defects in sodium transport in hypertension 
Abnormal cellular sodium content and sodium transport 
have been reported in hypertensive subjects and their 
offsprings. Tobian and Binion (1952) reported an increase 




sodium and Losse et al (1960 ) 
sodium content within the 
erythrocytes of hypertensive patients. 
14 
A decrease in the activity of the sodium pump , 
measured as the rate of ouabain-sensitive sodium ef flux, 
was found in the leucocytes of patients with hypertens i on 
(Edmundson et al 1975) and in some of their first-degree 
relatives (Heagerty et al 1982). Many independent studies 
have demonstrated that the abnormality of sodium transport 
is due to the presence of a ouabain-like sodium pump 
inhibitor in the plasma of hypertensive patients (Poston 
et al 1981 i Hamlyn et al 1982 i Buckalew & Gruber 1984) 
(see Section 2.4.). 
In 1980, DeWardener and MacGregor taking into account 
the various hypotheses proposed by previous workers 
suggested that a natriuretic hormone may be involved in 
the pathogenesis of hypertension. 
2.3. Hypothesis linking salt to the pathogenesis of 
hypertension - the natriuretic hormone (NH) 
There are many observations to support that the 
primary abnormality in H~ lies in the kidney. Tobian 
et al (1978) and ·Dahl and Heine (1975) pioneered the 
concept that an inherited renal defect is important in the 
pathogenesis of essential HT. In parabiosis experiments 
and renal cross-transplantation studies, Dahl and 
coworkers (1969) showed the presence of a natriuretic 
factor. Tobian et al (1978) have shown that in the Dahl 
salt-sensitive rats the ability to excrete a sodium load 
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strain. This abnormality could be demonstrated even when 
the animals were normotensive. In 1976, Haddy and 
Overbeck extended this hypothesis and suggested that the 
rise in blood pressure was due to a humoral factor 
associated with abnormal salt retention and the subsequent 
fluid volume expansion. Blaustein (1977) related the rise 
of this humoral factor to an increase in intracellular 
calcium via inhibition of the Na+-Ca+ exchange in vascular 
tissues. The vascular reactivity increased as a result of 
the intracellular calcium. DeWardener and MacGregor 
(1980a,b; 1983) summarised these and put forward a 
hypothesis which is shown in Fig. 2.3. They proposed that 
there 1.S a renal defect in those subjects who are 
genetically-predisposed to become hypertensive. When these 
subj ects increase their dietary sodium intake, ECFV 
increases. And as a protective mechanism, the body 
produces an endogenous digitalis-like "natriuretic 
hormone" which inhibits the sodium pump in renal tubules 
resulting in diuresis and restoration of salt balance. 
This putative factor or 'hormone' inhibits cellular 
Na+ ,K+-ATPase activity in various tissues. The 
inhibi tion of vascular Na + ,K+ -ATPase causes an increased 
intracellular calcium and this increases the contractility 
causing the elevation of blood pressure and development of 
essential HT (Blaustein 1977). The search for the 
existence of the natriuretic hormone has become the focus 
of many investigations. 
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2.4. Evidence for the presence of Natriuretic Hormone 
Although the natriuretic hormone (NH) has not been 
isolated, there are direct and indirect pieces of evidence 
to support the existence of this hormone. 
2.4.1. Indirect evidence 
Early studies found that in hypertensive animals the 
sodium content of renal arteries was increased and the 
ouabain-sensitive Rb uptake in mesenteric and tail 
arteries was reduced (Tobian & Binion 1952; Overbeck et al 
1976) . A high red cell sodium content and a reduced 
ouabain-sensitive sodium efflux was found in essential HT 
(Losse et al 1960; Waiter & Distler 1982; Brod et al 
1984) . Intracellular sodium concentration was found to 
be raised in the leucocytes or lymphocytes of hypertensive 
patients, which appears to be due to a reduction of the 
ouabain-sensitive Na+,K+-ATPase activity (Edmundson et al 
1975; Poston et al 1981; Heagerty et al 1982; Gray et al 
1984) . 
2.4.2. Direct evidence 
The presence of a circulating digitalis-like 
natriuretic hormone (NH) has been shown in the plasma of 
volume-expanded and salt-loaded animals (Gonick & Saldanha 
1975; Gonick et al 1977; Gruber et al 1980; Dewardener et 
al 1981; Hernandez and Godfraind 1984; Wauquier et al 
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1986; Goto et al 1989). Gonick et al (1977) demonstrated 
the presence of NH in the plasma of volume-expanded r ats 
and its inhibition on renal Na+,K+-ATPase. Gruber et a l 
(1980) prepared a purified plasma extract from saline-
infused dogs which inhibited brain Na+,K+-ATPase and 
cross-reacted with anti-digoxin antibodies. DeWardener et 
al (1981) found that the plasma from subjects on a high 
salt diet showed a much greater inhibitory activity on 
renal Na+,K+-ATPase than when the same subjects were on a 
low salt diet. Hernandez and Godfraind (1984) 
demonstrated the presence of NH in the serum of rats on a 
high salt diet and its cross-reactivity with anti-digoxin 
specific antibody. The plasma level of NH has also been 
previously observed to be elevated in rats chronically fed 
on a high sodium diet (Wauquier et al 1986). 
Direct demonstration of an inhibitory effect of 
hypertensive patients' plasma on sodium transport in 
normal cells provided further evidence. A low molecular 
weight substance that binds to digoxin antibodies and 
inhibits Na+,K+-ATPase activity was found in the plasma of 
hypertensive subjects (Poston et al 1981; Hamlyn et al 
1982; Buckalew & Gruber 1984; Kelly et al 1985) . The 
serum of essential HT patients has been shown directly to 
inhibit the ouabain-sensitive Na+ efflux in normal cells 
(Poston et al 1981) and in a more direct assay, the 
activity of renal Na+,K+-ATPase (Hamlyn et al 1982). 
Devynck et al (1983, 84a&b) demonstrated the presence of a 
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circulating digitalis-like factor in the plasma of 
hypertensive patients using competitive 3H-ouabain binding 
to the sodium pumps of normal erythrocytes. MacGregor e t 
al (1981) using a cytochemical assay demonstrated that the 
plasma from hyper~ensives inhibited Na+,K+-ATPase activity 
in vitro. Cloix et al (1985) purified a sodium pump 
inhibitor from human urine and demonstrated its inhibitory 
activity on ouabain-binding and cross-reactivity with 
antidigoxin antibodies. 
In conclusion, there is circumstantial evidence for 
the presence of a digitalis-like natriuretic hormone in 
hypertensive and volume-expanded subjects. 
2.4.3. The source and properties of natriuretic hormone 
The def ini t i ve origin of the endogenous NH is 
unknown. However, the area of periventricular tissue 
surrounding the anteventral third ventricle (AV3V) or the 
hypothalarnus has been incriminated as the probable source 
of this hormone in the rat (Brody et al 1978; Haupert et 
al 1984). This is based on the finding that the level of 
plasma sodium pump inhibitor is greatly reduced, and the 
development of hypertension is prevented by lesions in the 
medial AV3V region of the hypothalamus (Pamnani et al 
1981; Songu-Mize et al 1982). Such lesions also prevent 
other types of volume-dependent hypertension (Buggy et al 
1984) and reduce the secretion of a compensatory inhibitor 
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of the sodium pump following an expansion of the plasma 
volume (Pamnani et al 1981; Bealer et al 1983). 
It has been reported that NH is a heat-stable, low 
molecular weight substance (M.W.<l,OOO daltons) and 
inhibits Na+ ,K+-ATPase activity (Gonick et al 1977; 
Buckalew & Gruber 1984; Cloix et al 1985). 
This endogenous hormone has been shown to inhibi t 
specific ouabain binding 
uptake (Haddy 1984) and 
(Devynck et al 1983) and Rb 
cross-react with antidigoxin 
antibodies (Gruber et al 1980). It acts principally at 
the renal tubules and exerts a potent natriuretic effect 
(Gonick and Saldanha 1975). It is not a polypeptide and 
thus resists proteolysis (Cloix et al 1985; Goto et al 
1989). It can be isolated from the plasma of essential HT 
subjects and of subjects after acute or chronic sodium 
loading (Section 2.4.2.). 
To summarise, NH was found in the plasma of 
hypertensive and volume-expanded subjects. It resembles 
digoxin in inhibiting the activity of the sodium pump. 
2.4.4 Other natriuretic factors 
It must be noted that there are at least two other 
endogenous substances which cause natriuresis and 
diuresis. 
First discovered histologically in rat atrial 
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myocytes by Bompiani et al (1959), atrial natriu retic 
peptides (ANP) have been purified and struc turally 
identified (Atlas et aI, 1984). ANP is heat-stable, has a 
low molecular weight and increases in concentration in 
response to an increase in intravascular volume and sal t 
intake (Lang et aI, 1985; Sagnella et al, 1987). 
Both the ANP and the putative NH may be involved in 
the regulation of sodium reabsorption, but probably by 
different mechanisms. The putative NH acts via inhibition 
of the renal Na+, K+-ATPase activity and produces 
natriuresis. In contrast, ANP does not inhibit Na+,K+-
ATPase. It was proposed that ANP may act as an endogenous 
diuretics altering directly the permeability of the 
tubular epithelium to sodium (Pollack et al 1983) or it 
may alter intrarenal haemodynamics and thereby results in 
a potent and rapid natriuresis (deBold et al 1981). 
ANP also inhibit aldosterone secretion in vivo 
(Chartier et al 1984), cause vasodilatation (Deth et al 
1982) and reduce cardiac output (Ackermann et al 1984). 
Hence, they act as antihypertensive factors. These 
physiological roles of ANP suggest that they are local 
(atrial) regulatory mechanisms interacting with other 
components in an internal reinforcing system of regulation 
of body fluid volume and blood pressure. 
Dopamine is an endogenous intrarenal natriuretic 
substance associated with sodium loading (Lee 1986). In 
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healthy normotensive human subjects and rats, an increase 
in dietary NaCl intake increased the urinary dopamine 
output. (Ball et al 1986). The increase in urina r y 
dopamine was thought to be secondary to ECFV expansion 
(Ball et al 1978). Dopamine, the metabolic precursor of 
noradrenaline and adrenaline, is thought to be synthesised 
intrarenally from L-dopa by renal tubular dopa 
decarboxylase (Lee 1986). It functions as an intrarenal 
hormone promoting sodium excretion (natriuresis) in the 
control of water and electrolyte balance. It may act 
directly on the dopamine receptors in proximal tubular 
cells or vasodilate the efferent glomerular arteriole 
resulting in a fall in oncotic pressure and subsequent 
sodium reabsoption (Imbs et al 1984). 
It was found that in Caucasians with essential 
hypertension and a subgroup (salt-sensitive) of essential 
hypertensive Japanese, oral salt loading does not increase 
urine dopamine output (Casson 1984). Such a lack of the 
normal sodium-dopamine response in the kidney or defective 
renal dopamine production was hypothesised to be a 
predisposing mechanism to the development of hypertension 
when salt-sensitive individuals encounter a salt-rich diet 
(Critchley et al 1989). 
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CHAPTER 3 REGULATION OF THE SODIUM PUMP 
3.1. General introduction 
It is well known that there is cellular regulation of 
membrane receptors in response to agonists or antagonists . 
Membrane receptors undergo dynamic homeostatic regulation. 
The binding of ligands to receptors is followed by the 
"internalisation" process. Such internalisation or 
degradation of receptors occurs continuous ly and is 
balanced by ongoing de novo synthesis and insertion of new 
receptor molecules into the membrane (Grumbach 1987). 
This kind of receptor regulation is advantageous because 
it protects the tissues from prolonged or excessive 
stimulation or inhibition. For instance, p_rolactin 
administration results in up-regulation (i.e. increase) of 
prolactin receptors in liver cells (Grumbach 1987). 
Hyperinsulinaemia, found in obesity, results in a decrease 
in plasma insulin receptors (i.e . down-regulation), which 
accounts for insulin resistance (Grumbach 1987). 
3.2. Regulation of the sodium pump by intracellular 
sodium 
Experimental studies show that the sodium pump is also 
regulated like other receptors. 
activity may vary by three- to four-fold within a cell 
type (Lechene 1988). Such regulation of Na + I K+ -ATPase 
activity may be a short-term or long term event in 
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response to a change in the intracellular sodium 
concentration. An immediate or short term increase in 
intracellular sodium accelerates the Na+,K+-ATPase 
activity so that the cell reaches a new steady state. If 
the increase in intracellular sodium concentration is 
sustained, the long term regulation occurs with synthesis 
of new pumps (Lechene 1988). 
Experimentally, it was shown that [Na+Ji is a primary 
signal for the regulation of the cell surface density of 
Na + , K+ -ATPase. Exposure of myotubes to a low potassium 
medium and ouabain leads to an elevation of cytoplasmic 
sodium and this triggers off an up-regulation of Na+,K+-
ATPase (Lamb & McCall 1972; Vaughan and Cook 1972). 
Prolonged incubation of chick myotubes in 10umol/L 
veratridine, which enhances the opening of the vol tage-
dependent sodium channels, resulted in a 60 to 100% 
increase in the number of Na+,K+-ATPase molecules 
(Wolitzky & Fambrough 1986). . The . sodium pump is also 
.regulated by many hormones which act either by increasing 
its activity, e.g. insulin (Clausen & Hansen 1977; Rosic 
et al 1985), or by increasing the concentration of the 
pump sites, e.g. thyroid hormones (Ismail-Beigi & Edelman, 
1971; Everts et al 1988). In both cases, an influx of 
sodium is the inductive signal. 
The understanding of the regulation of Na + I K+ -ATPase 
activity is important with regard to the pathogenesis of 
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hypertension as it has been proposed that inhibition o f 
vascular Na+,K+-ATPase leads to hypertension. It is 
therefore important to review the regulation of the 
Na+,K+-ATPase activity following its inhibition by 
endogenous inhibi tors (e. g. na triuretic hormone) or 
exogenous inhibitors (e.g. digoxin). 
3.3. Effects of ethanol on Na+,K+-ATPase activity 
Israel and coworkers (1965) reported that sublethal 
concentrations of ethanol inhibited the active brain 
microsomal Na+,K+-ATPase activity. In a later study, they 
measured the changes in Na+,K+-ATPase activity produced by 
administration of 7%(w/v) ethanol to rats for four months. 
They found that the brain Na+,K+-ATPase activity was 65% 
higher in the ethanol treated group (Israel et al 1970). 
They concluded that the changes in pump activity were an 
adaptive change consequent upon chronic inhibition of the 
pump by ethanol. In alcoholics, the Na +, K+ -ATPase 
activity of erythrocytes was found to be 30% higher 
(Israel et al 1970). When HeLa cells were incubated in 
the presence of ethanol (21.7 or 43.3 mmol/l) for 1 to 5 
days, there was a s ignif ican t increase in the 
ATPase activity which was prevented by cycloheximide 
(Lindsay 1974). This finding suggested that the 
upregulation of Na+,K+-ATPase activity is due to de novo 
synthesis of new pump sites. 
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3.4. Effects of potassium depletion on Na+,K+~ATPase 
activity 
The requirement of Na + , K+ -ATPase for Na + and K+ is 
almost absolute and constitutes one of its fundamental 
properties (Skou 1957). Sodium pump has a higher affinity 
for extracellular potassium ion. The latter binds and 
induces specific conformational changes thereby activating 
the enzyme from the outside (Km = 0.5-1.8rnM) (Post et al 
1960 i Bonting 1970). Potassium is involved in the 
regulation of the Na+,K+-ATPase activity and the number of 
pump sites. 
3.4.1. In vivo studies of sodium pump regulation 
by potassium 
The effects of acute or chronic potassium depletion on 
Na+,K+-ATPase have been studied in both animals and human 
subjects in vivo. Kjeldsen et al (1984, 1986) studied the 
effects of short-term potassium depletion (for around two 
weeks) on Na+,K+-ATPase activity in both the rat and 
gUinea pig. They found that short-term potassium 
depletion was associated with a reversible (48%) reduction 
of 3H-ouabain binding sites (3 H- OBS ) in the skeletal 
muscle. Aalkjaer et al (1985) and Norgaard et al (1981) 
also reported that rats when potassium-depleted for four 
weeks had a decrease in 3H- OBS sites and an increase in 
[Na+Ji in the resistance vessels and skeletal muscle. 
However, long term potassium depletion resulted in an 
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increase in sodium pump activity. Chan and Sanslone (1969) 
studied the time-related changes of rat erythrocyte 
Na+, K+ -ATPase and demonstrated a significant increase in 
Na+,K+-ATPase activity in chronic potassium depletion 
beginning at the fifth week When rabbits and gUinea-
pigs were maintained on potassium-deficient diet for about 
14 days, the cardiac Na+,K+-ATPase showed no change 
initially but significantly increased towards the end of 
the treatment (Erdmann et al 1971; Bluschke et al 1976; 
Ward and Cameron 1984). Based on enzyme kinetics studies, 
Erdmann et al (1971, 1984) concluded that the increase in 
Na+,K+-ATPase activity was a quantitative change due to 
the induction of enzyme molecules (i.e. de novo synthesis 
of pump sites). 
In human studies, Bossaler and Schober (1982) have 
shown that the number of ouabain binding sites in red 
cells increased with potassium depletion. They found a 
correlation between the severity of hypokalaemia and the 
change in ouabain binding sites. Erdmann and coworkers 
(1977, 1984) also showed that an increase in red cell 
ouabain binding sites occurs in patients with chronic 
hypokalaemia during diuretic treatment. This increase in 
Na+,K+-ATPase activity has also been reported by 
Cumberbatch and Morgan (1983) in human red cells. 
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3.4.2. In vitro studies of sodium pump regulation by 
potassium 
Regulation of Na+,K+-ATPase activity by potassium has 
also been demonstrated in cultured and isolated cell 
preparations. The exposure of cells to a low potassium 
concentration in vitro leads to a progressive loss of 
intracellular potassium associated with a gain in sodium. 
studies with several types of cells have shown that after 
the initial pump inhibition, there is increased Na+,K+-
ATPase activity followed by de novo synthesis of more Na+-
K+ pumps. When HeLa cells are exposed to low extracellular 
potassium for several hours (Pollack et al 1981b), the 
Na+rK+-ATPase activity is stimulated to achieve a greater 
rate of sodium extrusion. In contrast to such short term 
regulation, HeLa cells grown in O.5mmol/L potassium medium 
for 24 hours showed a two-fold or greater increase in the 
number of Na+,K+-ATPase sites, as judged by ouabain 
binding (Boardman et al 1972, 1974, Pollack et al 1981a). 
Similarly, chronic exposure of fibroblasts and cardiac 
myotubes. (Werdan et al 1984) and avian myotubes 
(Fambrough & Bayne 1983) to low K+ led to a progressive 
increase in 3H-ouabain binding capacity and Na+,K+-ATPase 
activity. Kim et al (1984) cultured chick heart cells in 1 
mmol/L potassium medium for various durations and clearly 
confirmed a gradual induction of additional functional 
sarcolemmal Na+ -K+ pump sites upon prolonged potassium 
depletion. 
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In co ncl u s io n, t h e r e i s e xp e r i m n tal v i d n " - ( 
s uppor t tha t ch r on ic potass ium d eple tion r es ult i n a n 
adap t i v e increas e in the Na +,K+ - ATPase activ ity and t h · 
n umbe r of ouabain binding sites (OBS). 
3.5. Effects of cardiac glycoside on the sodium p ump 
Cardiac glycosides comprise a group of inotrop i c a nd 
chronotropic drugs obtained from the digitalis plant. Th e 
class i ca l experiment of Cattell and Gold (193 8) 
estab li s h ed t hat digitalis compounds ha v e a d i rec t 
positi v e inotropic effect on the myocardium. In 1953, 
Sc hat zmann demonstrated that the Na + , K+ transpor t on red 
b l ood ce l l membranes was speci fi cally inhibited b y card i ac 
glycos ides (Schatzmann 1953). Skou (1957) confirmed t h a t 
th e Na + , K+ -ATPase pump was specif i call y i nhibited b y 
ouaba in . Since t hen, numerous studies have shown t h a t 
Na + , K+ -ATPase is the specific membrane receptor for 
cardiac gl y cosides (Alien et al 1971) . . Cardiac glycos i des 
inhib it the pump at the outer surface by produc i ng a 
conformational change of the enzyme molecule. The 
inhibition results in an accumulation of intracellular 
sodium ions which displace bound calcium ions and 
activate Na+,Ca++-ATPase (i.e. an increased Ca++ influx), 
resulting in an elevated cytosolic calcium ion content and 
positive inotropic effects (Gibson & Harris 1968 ; Schwart z 
1976 ) . 
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Dig o x i n is now th e mo s t c o mm o n ly u ' ed c a rd iac 
gl ycosid e in clinic a l pra ctice. It s shor t h a l f- l if 
a llows easi e r management of toxicity and pla s ma l e v e l s c a n 
b e easily measured by commercial kits. Howeve r, d i g o x in 
toxici ty still remain a clinical problem because of i ts 
narrow therapeutic range (0.6-2.1 ng/ml) and the var ied 
organ responsiveness to the drug (Aronson et al 1978 ) . 
Ouabain, a rapid-acting cardiac glycoside, is seldom 
administered clinically but widely used in experimental 
studies. Several studies have shown that there is 
regeneration of Na+,K+-ATPase activity when cells or 
animals are exposed to cardiac glycosides for prolonged 
periods ( Section 3.5.1 and 3.5.2). 
3.5. 1. I n v ivo studies of sodium pump regulation by 
cardiac glycosides 
Bluschk e et al (1976) administered digitoxin 
subcutaneously to guinea pigs for 24 days and followed the 
c h anges in myocardia l Na+,K+-ATPase. They found an 
in i tial decrease (i. e. inhibition) over 1 to 5 days of 
treatment followed by a significant increase in the enzyme 
activity after 7-18 days, suggestive of an adaptive enzyme 
induction. Based on enzyme kinetics studies, they 
suggested that the increase in activity could be caused by 
an increase in the enzyme level. Similarly, Bonn & Greeff 
(1978) showed that treatment with digitoxin for five days 
did not affect the myocardial Na+,K+-ATPase activity i n 
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g uinea pigs , but treatment for 24 days led to a n l n cr a~ 
in the myocardial Na+,K+-ATPase activity. Lindsa y and 
Parke r (1976) showed that rats given digoxin orally for 4 5 
days had a higher hepatic Na+,K+-ATPase activity. 
In vivo studies in patients on digitalis treatment 
give support to t.his concept of upregulation of 
pumps. Kettlewell et al (1972) studied the intracellular 
ion contents of unselected patients receiving digoxin 
therapy and found a significant increase in the mean red 
cell sodium content and a progressive fall in red cell 
potassium during the first 48 hours of digoxin therapy. 
Cappuccio et al (1986) studied the short term effect of 
oral digoxin on Na+,K+-ATPase activity in normotensive 
subjects and found that five days' treatment caused an 
increased red cell sodium concentration. Similarly, Smith 
et al (1987) studied the effect of digoxin treatment for 4 
to 5 days on sodium transport of human erythrocytes and 
found a signif icant increase in the intracellular sodium 
concentration and a decrease in the number of 3H- OBS . Ford 
et al (1979a & b) investigated the acute and chronic 
effects of digoxin therapy on erythrocyte Na+,K+-ATPase 
activity by measuring the sodium content, digoxin binding 
and 86 Rb uptake, all being measures of sodium transport. 
They found a decrease in Na+,K+-ATPase activity in patients 
receiving acute digitalisation (in 2 to 4 days) but such an 
inhibitory effect was not observed in those on long term 
digoxin therapy (92-119 months). It was suggested that 
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t h r was a compe nsatory i ncrease o f me mbra n e sodium pump;- ' 
due t o d e novo synthesis. Similar find i ngs we r e r eporte 
by o t he r investigators (Morgan e t al 1980). Cumbe rba t c h et 
a l (1981) studied the early and late effects o f digoxin 
treatment on the erythrocyte sodium pump. They foun d an 
ini tial decrease in Na + , K+ -ATPase acti vi ty in short t erm 
digitalised patients followed by an increase in erythrocyte 
Na+ ,K+ -ATPase activity with longer duration of treatment 
(for more than two months). Whittaker et al (1982) studied 
the time course of changes of erythrocyte sodium pump 
activity in pigs receiving digoxin (0.04mg/kg/day) for 14 
weeks . They reported an initial inhibition of the sodium 
pump followed by an increase in Na+,K+-ATPase activity 
towards the end of treatment. 
3.5.2. In vitro studies of sodium pump regulation by 
cardiac glycosides 
In in vitro experiments using cells in culture, 
cardiac glycosides were found to have similar effects. 
When Hela cells and Ealb/3T3 cell lines were incubated for 
24 hours in 20nmol/L ouabain, new 3H- OBS were generated 
(Boardman et al 1972; Vaughan & Cook 1972). Kim et al 
(1984) studied the time-related changes of pump sites of 
chick heart muscle cells by incubating cells in medium 
containing lmmol/L ouabain. They noted a gradual increase 
in Na + I K+ pump sites when these cells were exposed to 
ouabain over a 48-hour period. Brodie and Sampson (1985 ) 
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m n rat d tha t wh e n rat s k e l e t a l myotu bes were cult .:.r 
for 2- 6 days in the chronic pre sence of oua bai n, there wa ' 
a gradual increase in the number of 3H- OBS . Th e 
r e gulation of pump activity is attributed to th e 
regulatory role of intracellular sodium content (Boardman 
et al 1972; Pollack et al 1981a & b· , Whittaker et a l 
1982) . Cells increase the number of sodium pump sites 
above normal in order to compensate for the the acute 
inhibition, thereby restoring the sodium and potassium 
contents of cells to normal. 
Rayson and Gupta (1985) demonstrated that superfusion 
of rat outer medullary segments with a medium containing 
10 mM ouabain over a period of 18 hours caused an 
increase in Na+,K+-ATPase activity by 60%. Intracellular 
sodium levels measured over the course of this response 
using nuclear magnetic resonance (NMR) techniques were 
nearly double that of controls when the period of exposure 
to ouabain was 2-4 hours. However, after 18 hours of 
supeifusion with ouabai'n, intracellular sodium levels were 
restored to control levels. This finding clearly showed 
that the synthesis of new pump sites is a homeostatic 
cellular response to maintain normal intracellular milieu. 
The compensatory increase in the number and activity 
pumps due to cardiac glycosides has not been 
shown in the brain tissue (Bluschke et al 1976). To date, 
there has been no study on the effect of cardiac 
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lyc id s on Na+ ,K+ - ATPase a ct i vity i n vascul a r t i u c.: 
I n summary, there is strong evide nce to show thdt 
a cut e treatment with cardiac glycosides c auses an 
inhibition of the Na+,K+-ATPase enzyme activity a nd a 
r eduction in the number of pump sites. Chronic trea t ment 
with cardiac glycosides results in an increase in th e 
number of the pumps and enzyme activity due to de novo 
synthesis. 
3.6. Effects of dietary salt on the sodium pump 
As described in Section 2.4, there is considerable 
evidence for the existence of a specific endogenous 
inhibitor of Na+,K+ pumps in the plasma or urine of 
hypertens i ve animals (the volume-expanded animal model ) 
and in some hypertensive patients (Haddy & Overbeck 1976; 
Gonick et al 1977; Kramer et al 1977; Wellard et al 1983). 
The release of this digitalis-like natriuretic hormone is 
expected to be associated with a reduction of Na+ K+-, 
ATPase act i vity. 
3.6.1. Acute effects of salt-loading 
Myers et al (1981) reported that the acute infusion of 
saline (225mrnol of Na+/Kg) over 30 minutes decreased the 
ouabain-sensitive erythrocyte total 22Na efflux in 
patients. When patients were acutely infused with 4 
litres of 150 mmol/L NaCl solution intravenously over fou r 
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h urs , Cos t a et a l (1981) foun d an incr a..J · 
intralymp hocyt e sodium. Quinta nilla et al ( 1988) s tud ied 
the s hort - t e rm effect (five days) of high salt diet In 
normotensive subjects and found a significant r e duct ion in 
the ouabain-sensitive Na+,K+-ATPase activity o f 
erythrocytes. Boero et al (1985) and Weissberg et al 
(1984) reported similar results of pump inhibition after 
acute saline infusion. Costa et al (1981) and Wauquier et 
al (1986) showed that rats given a high salt diet (8% 
NaCl) for two weeks had a higher intra-erythrocyte sodium 
content (i.e. greater inhibition of sodium pump) compared 
to control animals. However, the intra-erythrocyte sodium 
content returned to control levels after three months of 
high salt intake. This indicates that the effects of salt 
loading on the Na+, K+ pump depend on the duration of salt 
loading. 
3.6.2. Chronic effects of salt-loading 
Bradlaugh et a l (1984) reported that rats given a high 
salt diet for one month had a higher Na+,K+-ATPase 
activity in the thymocytes compared to control animals. 
Wald et al (1983) studied the effects of feeding rats with 
1.7% NaCl for two weeks. They found that the 
ATPase activity of crude renal homogenate and medullary 
microsomes were increased significantly. Swann (1985) 
reexamined the chronic effect of high salt intake (5% NaCl 
for 4 weeks) on tissue Na+,K+-ATPase activity in rats and 
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h \..J d s i gn if ica nt i ncre a se in Na+ , K+- ATP as cti v it y 
nd t h e numbe r of ouabain binding s ites i n t h e k idn e y but 
n o t in the cerebral cortex or the h e art. The a u thor 
suggested that there was a compensatory de novo synthes i s 
of pump sites in response to the increase in circula t i n g 
natriuretic hormome. 
There are a few studies on the effects of salt-loading 
on vascular Na+,K+-ATPase activity. Bradlaugh et al 
(1987) showed that the aortic sodium pump activity in 
salt-loaded rats as determined by 22Na efflux rate was 
similar to the control values after one month of high salt 
in take ( 1 . 7 % NaC 1 ) . Vasdev et al (1988) studied the 
effect of 4 weeks of high salt diet with 8% NaCl on salt-
sens i t i ve and salt-resistant rats. They studied the 
v ascular sodium pump activity by measuring the 86 Rb uptake 
in v i tro and found that the high salt diet increased the 
pump activity in both salt-sensitive and salt-resistant 
rats. They suggested that the increased pump activity 
could be due to an increase in the concentration of 
intracellular Na+ or to an increase in the density of pump 
uni ts on the cell membrane or both. In these two 
studies, there was no evidence for a decrease in vascular 
Na+,K+-ATPase activity due to endogenous inhibitor(s) in 
salt-induced hypertension. 
37 
I n ununa r y, t h r e i s e v ide n ce to s uppo rt th t v o1 rrl 0 
x p n sion b y c h ro n i c sa lt loadi n g leads to a n a d pt i v e 
re g nerati on o f Na+ ,K+-ATP a se activity and mol e cu le s . 
Hhether the vascular Na+ ,K+ - ATPase behaves i n a s imil a r 
fa shion remains to be seen. 
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C1-L~PTER 4 AIMS OF THE STUDY 
There is increasing evidence for the existenc e of a 
digitalis-like natriuretic factor in the volume-expanded 
model of hypertension (Section 2.4). DeWardener and 
MacGregor (1980 a&b) have proposed that this humoral 
natriuretic factor causes inhibition of Na+ ,K+ -ATPase in 
vivo leading to enhanced vascular contractility, 
resulting in increased total peripheral resistance and 
blood pressure (Overbeck et al 1976; Blaustein 1977). 
If such a hypothesis is true, the Na+,K+-ATPase 
activity in various tissue cells of hypertensive subjects 
should be cons istently reduced. However, there is 
evidence to suggest that when the sodium pump is inhibited 
chronically, there is compensatory increase in Na + , K+ -
ATPase activity and the number of pump sites (Chapter 3). 
It is of pathophysiological signif icance, therefore, to 
examine the effects of endogenous natriuretic factor(s). 
There are many methods to expand the extracellular 
fluid volume (ECFV). Amongst them, salt-loading is a 
relatively simple and direct manoeuvre. In the present 
study, the effect of salt-loading of various durations on 
the changes in Na+,K+-ATPase activity was studied. These 
changes were compared to those produced by adrninstration 
of an exogenous inhibitor, i.e. digoxin. 
39 
Th i ms o f t h e prese nt st ud y we r e t h er e for ) Ci:': 
follows : 
1 . To e stablish a sensitive and precise method to me a s ure 
Na+,K+-ATPase activity in vascular tissue; 
2 . To study the short-term and long-term effec ts of 
digoxin on Na+,K+-ATPase activity; 
3. To study the short-term and long-term effects of salt 
loading on Na+,K+-ATPase activity. 
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HA TER 5 MEASUREMENT OF THE SODIUM PUMP / N a+ , K~ -
ATPa s e ACTIV ITY 
5 . 1 . Ge n e ral introduction 
The aim of this chapter is to review curre nt me t h ods 
available for the measurement of Na + ,K+ -ATPase acti vi ty . 
The sodium pump is a membrane-bound enzyme receptor 
which couples the transport of sodium and potassium with 
the hydrolysis of ATP (Skou 1988). There are basical l y 
three different methods to study the sodium pump, namely, 
its transport activity, the concentration of pump sites 
and the enzyme activity. The transport of sodium and 
potassium can be measured using radiolabelled isotopes 
22N a or 86 Rb in intact cells. In cell fragments or purified 
enzyme preparat i on where movements of Na+ and K+ cannot be 
seen, t h e enzyme is still capable of hydrolysing ATP in 
t h e presence of Na+, K+ and Mg++ (Skou 1988) . The rate of 
production of inorganic phosphate (Pi) and ADP represents 
the activity of Na+,K+-ATPase. These assay techniques are 
relatively easy to perform and are the popular methods of 
measuring Na+,K+-ATPase activity. The number of sodium 
pump sites can be determined by radioligand binding studies 
using 3H-ouabain (Albers et al 1968; Matsui and Schwartz 
1968) . 
41 
Th m s ur me nt o f Na +,K+-ATPase acti v ity. 
S . 2 . 1 . The sodium pump transport activity 
Na+,K+-ATPase can be estimated in terms of its 
f unctional correlates, i.e. active cation transport, using 
intact cell preparation or resealed vesicles. The 
ouabain-sensitive uptake of 42K or the efflux of 22 Na are 
common methods (Akera 1984). 
The 22Na efflux assay 
In this method, isolated intact cell preparations are 
used (Smith & Samuel 1970). The cells are incubated in a 
shaking water bath at 37 0 C in an isotonic solution at pH 
7 .4 containing a known amount of 22 Na . After a loading 
period of 3 hours, the cells are throughly washed (six 
times) with chilled buffer. The 22Na-loaded cel l s are 
then incubated in an isotonic buffer solution with and 
without ouabain over a defined time period. 
The total radioactivity of sodium appearing in the 
medium over a period of time is determined and the 
fractional efflux rate is then calculated. The ouabain-
sensitive sodium efflux rate is the difference in the flux 
rate in the presence and absence of excess ouabain. One 
of the disadvantages of this method is the use of 
radioactive 22 Na . Another disadvantage is the rapid 
changes in the specific radioactivity of intracellular Na + 
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r s u lti n g f rom the re l at ive s ma ll siz e of the 
p 1 (Ake ra 198 4 ). 
odium ion 
The sodium efflux rate can also be d e t ermi n ed by 
mea surement of sodium by atomic absorption spec t roscopy 
( Smith et al 1987), thus avoiding the use of radioisotopes . 
The 86 Rb uptake assay 
Rubidium is used very often as an analogue of 
potassium because of its longer half-life (18.7 days ) 
compared to that of potassium (13.4 hours). It was also 
demonstrated that the sodium pump handles 86 Rb and K in a 
simi l ar way. In this method, bot h intact tissues (e. g 
thin muscle slices) or intact cells (e.g. vascular s moot h 
musc l e cells, erythrocytes) can be used. For example, 
was hed eryt h rocytes are incubated in a potassium-free 
buffer solut i on containing a known amount of 86 Rb 37°C. 
After a f ini te t i me period, the cells are withdrawn, 
centr i fuged and washed to remove extracellular 86 Rb . The 
ce ll s are deproteinised and the intracellular 86 Rb 
counted. Active 86 Rb uptake is calculated as the 
difference in values observed in the presence and absence 
of high concentration of ouabain (e.g. O.lrnmol/L) (O'Neill 
& Mikkelsen 1987). 
One advantage of these methods is that they measure 
the ongoing sodium pump activity. These methods are based 
on an assumption that the coupling ratio between Na+ and 
43 
Rb+ j K+ ( 3 : 2 ) is f ixe d. Howe ver , th is tran s po rt rat i m y 
v a ry unde r diff e rent experime ntal conditions (Ake ra et al 
1 9 81) . El e ctrical stimulation increases t h e o uabai n -
s e nsitive 86Rb uptake. A recent report suggeste d that 
86 Rb uptake is an unsuitable method of measuring sodium 
pump transport activity in innervated tissues (Powis & 
Madsen 1986). 
In vivo measurement of Na+ transport activity 
The sodium transport activity can also be studied i n 
v i vo (Bonn et al 1984b). In this method, a fixed amount 
of rubidium chloride dissolved in water is administered 
ora lly at defined time intervals. Rubidium is taken up 
int o cells mainly through the action of Na + ,K+ -ATPase. 
The c l earance of rubidium from the plasma into the tissues 
or cells reflects the Na+ ,K+-ATPase activity. Blood 
samp l es are taken at hourl y intervals after the 
administration of rubidium. The rubidium concentration in 
t he plasma and cells is determined by atomic absorption 
spectrophotometry. 
The great advantage of 
activity in vivo is that 
studying the Na+,K+-ATPase 
it avoids the artefacts 
introduced during the course of experiments in vitro. For 
example, isolation of cells from whole blood may "alter 
their Na+,K+-ATPase properties, and the measured activity 
may not reflect sodium transport in vivo (Poston et al 
44 
1 ) . Mor import a ntly, the Na+ ,K+-ATPase a c ti v ity I n 
v i v may b e influence d by plasma - borne factor s suc h a s 
e n doge nous digitalis-like factor (EDLF) wh ic h may b e 
remove d or inactivated during experimental proce du res i n 
v i tro (DeWardener & Clarkson 1982). 
5.2.2. Quantitation of the number of sodium pump sites 
It was observed that radiolabelled 3H-ouabain or 3H-
digoxin binds specifically to active catalytic sites of 
the sodium pump (in the ratio 1:1) to i nduce 
conformational changes (i. e. phosphorylation) of the 
enzyme molecules and cause inhibition of the pump (Albers 
et al 1968; t-'1atsui & Schwartz 1968). 3H-ouabain is t h e 
preferred ligand for the quantitation of the active sodium 
pump sites because of its high affinity and low lipid 
solubility (A k era 1984). There is a stoichiometric 
relationship between ouabain binding capacity and 
hydrolytic activity of Na+,K+-ATPase (Jorgensen & Skou 
1971 ) . 
The specific binding of 3H-ouabain to membrane-bound 
Na+,K+-ATPase is a time- and temperature-dependent process 
following the Law of Mass Action (Erdmann & Hasse 1975). 
It requires the presence of Na+, Mg++ and ATP, the so-
called Na+,Mg++-ATP-dependent binding. In this method, 
cells are suspended in a buffer solution and aliquots of 
the cell suspension are incubated at 37 0 C with a known 
amount of 3H-ouabain and increasing concentrations of 
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un b lled o u a bain for a fi n it e t i me period . Th 
t h e n \vas h e d. Bound r a dioa ctiv it y i s e lu ted from th ~ 
ce l ls a nd 3H radioactivity count e d using a g a mma liqu id 
sc i n tillation counter. Scatchard analysis ( Bo u nd / Free 
v s total bound ouabain) is done to determine the number 
o f 3H-ouabain binding sites (3 H- OBS ) (x-intercept) and the 
dissociation constant (Kd) (Scatchard 1949). Non-spec i fic 
binding is determined in the presence of an excess 
(1 00umol / L) of unlabelled ouabain. 
The 3H -ouabain binding assay is not free fro m 
problems. Accessibility of the ligand binding sites and 
equi l ibrium binding are to be ensured during t h e 
experiment. Special counting devices, separa t ion steps 
are requ i red. The existence of nonspecific binding si t es 
and binding to nonfunctional pumps often comp l icates 
data analysis. The slow binding of ouabain to 
ATPase makes it di f ficult to obtain v a l ues at equili b rium. 
The turnover number (molecular activ i ty) of the enzyme is 
ass umed to be i ndependent of the experimental var i ab l es 
(Akera 1974). Despite these pitfalls, one big advantage of 
the radioligand binding method is that it provides 
information on the changes in the number of pump sites and 
their affinity for the glycoside in relation to the Na+,K+-
ATPase enzyme activity. Determination of 3H-ouabain 
binding in vivo could also provide information about the 
binding and distribution of digitalis glycosides in the 
i ntact organism (Norgaard 1986). 
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'r h measure me nt of enzyme activity 
5 . 2 .3. (a) Introduction 
Na+,K+-ATPase is the enzyme representation of the 
sodium pump. It hydrolyses ATP into ADP and Pi in the 
presence of Na + ,K+ and Mg++. Experimental work has 
elucidated the following stepwise reactions (Skou 1988) I 
viz. I 
Na+ 
(1) El + ATP --------------) E1~P + ADP 
(2) E1~P ------------------) E2~P 
K+ 
(3) E2~P + H20 ------------) E2 + Pi 
(4) E2 ------------------) El 
El and E2 being 
enzyme molecule. 
the two configurations of the 
step One is a Na+-dependent phosphorylation and step 
Three is the K+-dependent dephosphorylation. In SteD Two, 
conformational changes of the enzyme molecule occurs with 
a shift of affinity from Na+ to K+. step Four represents 
the regeneration of pump units. Inorganic phosphate (Pi) 
is the final product of ATP hydrolysis whereas ADP is 
formed in the Na+,Mg++-dependent phosphorylation. 
The Na+,K+-ATPase activity of a membrane preparation 
can be determined by one of three ways moni taring the 
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r t 0 p r oduction of Pi , mo n i t oring th r t of AD}) 
p r oL uction or the meas ure me nt o f the r at e o f K+- d p nd n 
p h sp h a t a s e activity (i. e. step Three o f th e abov e 
st e pwi se reactions). 
5.2.3.(b) Preparation of tissues and detergent treatmen t 
To determine Na+,K+-ATPase enzyme activity, a crude or 
microsomal membrane preparation is required. 
In order to extract the sodium pump which is an 
i ntrinsic component of plasma membrane and to prevent 
resealing of membranes with formation of vesicles, various 
detergents are employed (Jorgensen 1988). Prior to t h e 
e n z ym e assay I the treatment of crude homogenate or 
mi crosomal preparations with detergents that do not 
so lubilise or disrupt the Na + , K+ -ATPase is necessary . 
Jorgensen and Skou (1971) carried out a detailed study of 
the effects of t h ree common detergents deoxycholate 
(DOC), sodium dodecyl sulphate (SDS) and Lubrol 14, on the 
medul lary microsomal Na + ,K+ -ATPase. They found tha t DOC 
treatment increased the specific activity of Na+,K+-ATPase 
from 45 to 270 umol Pi mg- 1 protein hr- 1 . Lubrol 14 and 
SDS activated the enzyme to a lesser degree. SDS has a 
10-fold lower critical micelle concentration (CMC) than 
sodium deoxycholate and it requires the presence of 1% 
bovine serum as a buffer for the detergent. Lubrol 14, a 
nonionic detergent, solubilises the enzyme protein to form 
a soluble complex which needs subsequent centrifugation and 
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, lri£ic tion. Sodium deoxycho la t e i s a n ideal d t rg n . 
It s CMC is r e latively high and the optima l conce n tration 
fo r d e ma sking is independent of protein concentration . 
This detergent removes the inert membrane proteins, r e duc es 
the level of Mg++-ATPase, and exposes the latent 
ATPase binding sites as a result of opening of microsomal 
v esicles (Jorgensen & Skou 1971; Jorgensen 1988 ) . 
Activation by detergents, however, must be carried out at 
the CMC as higher concentration of detergents inhibits the 
enzyme activity (Jorgensen & Skou 1971; Norgaard et al 
1984; Skou 1988). The critical concentration of Doe 
necessary for maximal activation of Na+,K+-ATPase was 
determined in this study. 
S.2.3.(c ) Measurement of ATPase activity by measuring the 
rate of release of inorganic phosphate 
Gene~al considerations 
I n this met hod, tissue preparations containing Na + , K+-
ATPase are incubated in a buffer solution (optimal pH 7.2-
7.4) containing Na+, K+ and Mg++ and ATP. Since the Mg++-
ATPase of various subcellular origins are also activated 
under these conditions, it is necessary to subtract this 
'basic' Mg++-ATPase activity. This is usually done by 
concurrently assaying the Mg++-ATPase activity in a medium 
either free of Na+ and K+ or containing high concentration 
of ouabain - a specific Na+,K+-ATPase inhibitor. 
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Th Na+ , K+- ATPase e n z yme activ ity c a n the n b e cCl l cul - t 
as the di ffe renc e b e tween the 'tota l' ATP as e a ct i v it y 
o bs e r v ed in the pre sence of Na+, Mg++ and K+ a n d t he 
'bas ic' Mg++-ATPase activity observed in one of the abov e 
conditions. 
The ATPase activity measured as the difference in 
values observed in the presence and absence of Na+ plus K+ 
is sometimes called the 'Na+, K+-activated ATPase', 
whereas the one observed in the presence and absence of 
ouabain i s called the 'ouabain-sensitive Na+, K+ -ATPase'. 
In highly purified enzyme preparations, these t r,.;o va l ues 
are very c l ose to each other and can be used 
i nterc h angeably . Lack of agreement does occur, 
parti cu l ar ly when there is con t aminat i on of t h e reaction 
mi x t u re from tissue Na+ and K+ (Akera 1984) or reagents 
( e.g. ATP, buffer). In this situation, there is 
underestimation of Na+,K+-ATPase 
Na + inhibits t h e mitochondrial 
activi ty. 
Mg++-ATPase 
In addit i on, 
( Ake r a 198 4) 
wh i c h const i tute a substantia l part of observ ed Mg+ + -
ATPase in crude muscle preparations ( e.g. cardiac muscle 
homogenates). Ismail-Beigi and Edelman (1971) and Smith 
and Peters (1980) found that the use of sodium azide 
(NaN 3 , final concentration 5mM) inhibited mitochondrial 
Mg++-ATPase activity and reduced this problem. 
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Oll b i n 
I n d e t e rmining the Na+,K+-ATPa se a ctivity by u sing 
o u a b a in, the concentration of ouabain a nd t i me o f 
inhibition are critical. The interaction between ou a bain 
and the enzyme is a relatively slow process which requ i r es 
ATP and Na+ and it is delayed by K+. In order to achieve 
immediate and complete inhibi t ion of + + Na ,K -ATPase, 
ouabain concentration should be at least 1,000 times the 
Kd. Ouabain sensitivity differs greatly among species 
(Tobin et al 1972). It was found that 1mrnol/L ouabain was 
sufficient for complete inhibition of rat + + Na ,K -ATPase 
which has a low affinity for ouabain (Li 1984; Skou 1988). 
Subs t rates 
The concentration of ATP in the assay medium is 
usually 2 to 5 mrnol/L. A lower ATP concentration with 
excess Mg++ is preferred as high ATP concentration may 
inhibit enzyme activity. Since Na+ and K+ show reciproca l 
antagonistic activation of Na+, K+ -ATPase activity, the y 
are usually added in an optimal ratio of about 6 (Na) 1 
(K) (Skou 1988). Studies of the effect of magnesium (Mg) 
concentration on the enzyme activity revealed that the 
highest enzyme activity was found at a concentration of 
1.0 rnmol/L of Mg (Kirk 1959). The pH optimum for Na+,K+-
ATPase activity at 37 0 C is about 7.2-7.4 (Skou 1988). 
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The e n z yme r e action is usua lly ca r ri e d out at 37 0 C fo r 
15 to 6 0 minutes, the length of incubation d e p e nde n t on 
the en z yme activity. Ice-cold trichloroacetic acid or 
pe rchloric acid is added (final concentration 5 - 10 %) t o 
t e rminate the reaction. The reaction mixtur e i s 
centrifuged and the inorganic phosphate in the superna tan t 
is measured by either the Fiske and Subbarrow method 
(1 9 2 5) or other suitable colorimetric methods (e.g. 
Bo n t ing et al 1970). Protein content is determined e i t her 
b y t h e Lowry method (Lowry et al 1951) or other met h ods 
s u c h as t h e Coomassie Brilliant Blue method (Bradford 
1 976) to ca l culate the specific activity of t h e Na+ K+-, 
ATP as e (i .e. umoles Pi mg- 1 protein hr- 1 ). 
Thi s assay methodology using tissue homogenate or 
parti a lly p u r ified enzyme preparation is relat ively eas y 
to perform, and interpretation of results among different 
p re parations i s also relati vely straight forward. It is 
fre e from radiohazards and t he measurement of inorganic 
phosphate can be automated. However, the linearity of the 
reaction and incubation time should be checked. One other 
concern is the performance of this method to assay low 
Na + ,K+-ATPase activity in tissues containing high non-
s pecific ATPase activity (e.g. crude tissue or muscle 
p r e parations) . 
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5 . 2 . j • ( The couple d- e nzyme assay 
In this assay, another product of ATP hydrolysi s , AD P , 
is monitored photometrically by using an couple d -en z yrne 
oxidation of NADH (Schwartz et al 1969; Akera 1984; Horga n 
& Kuypers 1987). In this method ATP hydrolysis is coupled 
to NADH oxidation which is continuously monitored at 340nm 
by a temperature controlled recording spectrophotometer. 
The reactions involved are as follows: 
Mg++ K+ Na+ , , 
ATP + H20 -----------------------) ADP + Pi Na+,K+-ATPase 
Mg++, K+ 
ADP + PEP -----------------------) ATP + pyruvate 
PK 
LDH 
pyruvate + NADH + H+ ------------) NAD + lactate 
There is a stoichiometric relationship between the 
oxidation of NADH and the amount of ADP generated. The 
'basic' Mg++-ATPase is measured by the addition of ouabain 
to the incubation mixture to inhibit the Na+,K+-ATPase 
activity. Potassium-free medium cannot be used because 
pyruvate kinase activity requires potassium ions. Enzyme 
activity may be calculated from the decrease in absorbance 
at 340nm upon the addition of a known quantity of ATP. 
The advantage of this method is that the reaction can 
be continuously monitored. The concentration of ATP is 
maintained at a constant level and this avoids substrate 
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1 1 l n. Th nd product AD P l r In OV d 'o n .-.i tan - y , 
n ki n p r o uct in h ibition unl i k e ly. The lin rit y o[ 
r ction ove r time ca n b e easily check e d . The coupled-
e n z yme assa y of Na + I K+ -ATPa s e is claime d to b e mor e 
sensit ive than the t r aditional Pi release me t hod and i s 
used t o me asure low en z yme activity (Wald e t al 1985b) . 
5 .2 .3 . ( e) The K+-stimulated 3-0-MFPase assay 
Na + , K+ - ATPase c ata l yses a K+-st imu l ated hyd ro lys i s o f 
p - n itrophenyl phos phate (p- NPP) (Judah et a l 19 62 ) a nd 
3- 0 - me thylfl uor e sce nt phospha t e (3-0- l1 FP) ( Hua n g & As kar i 
1975 ) in th e p resence o f magn es ium i o n s. Thi s K+ -
dependent pho s p h at ase ac tivity i s re lated t o th e 
dep ho s pho r yl a tion s t ep of I 4-the Na ' , K ' - ATPase reac ti o n . The 
~ KT - d e pende nt phospha t ase ac tivi t y and + Na , K ' -ac tiva t e d 
ATPa se hydro lys i s are probably the properties of the same 
en z yme, Na + , K+ - AT Pa se ( Albers & Ko v a l 19 66; As k ar i & Ko y a l 
p - NPP has b e en e xt ens ive ly used a s a subs t rate f or 
Na + ,K+-ATPase measurement. But the assay is difficult to 
perf orm due to its low sensi t ivity. It requires ice-cold 
acid to terminate the reaction and KOH to raise the pH 
value to improve assay sensitivity. Continuous monitoring 
o f the reaction is thus not possible. Horgan and Kuypers 
(1 987) compared the ATPase activity using fluorigenic 3-0-
MFP, ATP and pNPP as substrates. It was found that 
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- - ~l F l q u l ly a good s u b t r t - ~ pIl l ) . f l ,I ' 
u r i m tric ssa y u s ing 3- 0 - MFP has th - a d d 
of requiring 50 to 100 time s l e ss e nzyme pro tein t h n -h --
r e qu i r e d for the p-NPP. The high ratio b e twee n th K -
dependent phosphatase and total phosphatase ac tivity 
renders the assay a more sensitive and accurat e assay 
(Huang & Askari 1975,1976). 
The 3-0-MFPase reaction is shown as follows: 
K+,Mg++,Na+,K+-ATPase 
pH 7.6 
3-0-MFP -----------------------) 3-0-MF + Pi 
(3-0-methylfluorescein (fluorigenic 
phosphate) product) 
Experimentally, the fluorescence spectrum of the 30MF 
is first obtained. Previous workers have verif ied the 
close correlation of K+-stimulated 3-0-MFPase activity 
with Na+,K+-ATPase activity. Enzyme kinetics studies 
demonstrated the K+ -dependent phosphatase activity obeys 
t h e "1 i c h a e 1 i s - 11 e n ten Kin e tic s wit h res D e c t tot h e 
substrate 3-0-MFP. The Vmax was also in the same range as 
when measuring Na+,K+-ATPase activity (Robinson et al 
1978) . The K+ -dependen t 3 -O-MFPase acti v i ty can be 
completely inhibited by ouabain (Skou 1960). Norgaard et 
al (1984) estimated the K+-dependent 3-0-MFPase activity 
and 3H-ouabain binding of crude homogenate of rat skeletal 
muscle. These workers found a good correlation between 
the 3-0-MFPase activity and 3H-ouabain binding, bot h 
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ump . Au 
p if i c 
b i n g i n t i ma t l y as o ci a t d wi h t h _. 11 -t 
p r e v iou s l y m nt ion ed , t h 
ATPa s e a ctivity present l n 
l arg - moun - o f 
mu s cl e pr p r 
, 
K t _ 
r Jr 
lO . ..; 
ma k e th e measur e ment of Na+,K+ - ATP as e l n crud e or 
microsomal preparations unreliable . Thi s pit fall i s 
a g g ravated when the Na+,K+-ATPase activity to b e measure d 
is very low, such as in crude homogenates of va s c ula r 
smooth muscle. The K+ -dependent 3-0-MFPase assay i s an 
ideal substitute for Na+,K+-ATPase measurement. 
The 3- 0 - MFP met h od has been used to measure t h e . 
Na+,K + -ATPase activ i ty of crude homogenates of rat 
s k e l etal muscle (Norgaard et al 1984), the cardiac musc l e 
i n cardiomyopat h ic ha msters (Norgaard e t a l 1987 ) and the 
t ra n s v erse t u bules of rabbit long i ss i mus dorsi mu sc l e 
(H orga n & Ku y pers 1987). 
I n summary, t here are· a number of met hods avai l ab l e 
t o measure the acti v ity of t h e sodium pump. The th ree 
me thods of measuring Na+,K+-ATPase activit y were 
es tabli s hed an d eva l uated i n the present study. 
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h r METHODS - ESTABL ISr~ENT AND EVALUAT I 
I n t his chapter, the ma t e rials a nd method.' of th· 
p rese nt study are described. The thr ee me thod of 
measuring Na+ ,K+-ATPase enzyme activity de s cr i b ed in 
Chapter 5 were established and evaluated. Th e f i n al 
section of this chapter is devoted to the results of 
evaluation and discussion of these methods. 
As described in Chapter 5, there are three methods to 
measure the enzyme activity of Na+,K+-ATPase. The rate of 
phosphate (Pi) release method is the most conventional and 
popular choice. This method was thus first established 
and evaluated. 
6. 1 . Chemicals 
Al l chemicals, including ouabain octahydrate, 3-0-
methyl-fluorescein (3-0-MF) and 3-0-methylfluorescein 
phosphate (3-0-MFP) I were of analytical grades and 
purchased from Sigma Chemical company (st. 
Minnesota, U.S.A.), unless stated otherwise . 




b. 2 . + + Meas ure me nt of Na ,K - ATPase activi t y by th e 
o f re l ease of inorga n i c phos phate . 
Rea g e nts: 
(A) Incubation Buffer 









pH was adjusted to 7.4 at room temperature 
with concentrated HC1(0.lmol/L) and stored at 4 0 C. 
(B) Ouabain solution 
0.073g of ouabain was dissolved in 10ml DDW to make up 
a lOmrnol/L ouabain solution. This solution was made fresh 
daily prior to use. 
(C) ATP Stock 
O.165g ATP disodium salt (Grade 1, Sigma Chemical 
Company) was freshly dissolved in 10ml of the reacti o n 
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u ff r t m- k up a 30mrnol/L 0tock s olu ti on pr i or - 0 ~( (.: 
ss y . It was added propo rtion a lly to the r action t c; 
to achieve a final concentration of 5mrnol/L . 
(D) Trichloroacetic acid 
A 30%(w/v) TCA was prepared by dissolving 30g of 
trichloroacetic acid in 100ml DDW and stored at 4o C. 
(E) Inorganic Phosphate Reagents 
The inorganic phosphate determination is based on t he 
reaction of molybdate with phosphate to form a stable 
yellow heteropolyacid complex which lS quantitated at 
340nm ( Daly & Ertingshausen 1972). 
Reagent 1 
Reagent 2 
it consists of 450 mrnol/L su lphu ric 
acid and 1.1 mrnol/L ammonium molybdate; 
this is a Tween 50% surfactant solution. 
The working reagent was prepared by adding 1 part of 
Reagent 2 to 26 parts of Reagent 1 and mixing well. 
used within 8 hours. 
(F) Phosphate Standards 
It was 
Phosphate standards (0.646 mrnol/L and 1.292 mrnol/L) 
were purchased from New England Reagent Laboratory. 
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o f i nor 3n ic p ho s p h t 
The measure ment of inorganic phospha t e by the method 
o f Daly and Ertinshausen (1972) was aut o mated in a 
c e ntrifugal analyser (Cobas Bio, Roche Compa ny, Basle , 
Swit zerland). The parameters for the phosphat e me asurement 
is shown in Fig. 6.1. 
Ten microlitres of 




at 30 0 C for 
30 0 
12 
minutes. The absorbance was then read at 340 nm. Water was 
used as the blank. 
Assay orocedure: 
Th e measurement of r e nal and vascular Na + , K+ - ATPase 
was attempted u Slng t h e rate of ouabain in h ib it ab l e 
re l ease of Pi from ATP.100u l of crude tiss u e preparations 
were incubated at 37 0 C for 10 minutes in 300u l of reaction 
buffer wi t h and wi t hout ouabain, a specific inhibitor of 
N a -+- , K + - AT Pas e , a t a con c en t rat ion 0 f 10 mm 01 / L . Th e 
reaction was started b y the addition of 100ul of ATP stock 
solution. The final concentrations of the reaction 
mixture were (mmol/L) NaCl 100, KCl 15, MgC1 2 4, EDTA 1, 
NaN 3 5, ATP 5 and d-Histidine 30. The reaction mixture 
was incuba ted for 30 minutes and the react ion was 
terminated by the addition of ice-cold 5% (fina l 
concentration) trichloroacetic acid (TCA). The react i on 
tubes were quickly vortexed and centrifuged at 6,000 rpm 
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( 1) unit s nmol / L 
( 2 ) Calculation factor 0 
(3 ) Standard 1 conc 6 4 6 
( 4 ) Standard 2. conc 1292 
(5) Standard 3 conc 0 
( 6) Limit 2000 
(7 ) Temperature [deg. C] 30.0 
( 8 ) Type of analysis 5 
( 9 ) Wavelength [run] ]40 
(10) Sample volume [ul] 10 
( 11) Diluent volume [ulJ 24 
(12) Reagent volume [ul] 300 
( 13 ) Incubation time [sec] 0 
(14) Start reagent volume [ulJ 0 
(15) Time of first re2ding [sec ] 0.5 
(16) Time interval [sec] 360 
(17) NUJL1ber of readings 2 
( 18 ) olanking node l 
(19) Printout mode 1 
Fig.6.l. . . Parameters for the measurement of lnorganlc 
phosphate in the centrifugal analyser 
(Cobas Bio; Roche, Switzerland) 
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r minut s ( Epp ndof f C nt rif u g , Roch ~ ) . 
i n rg nic phos pha te ( P i) i n t h e s u p e r n a ta n t wa · m su .( 
by the me thod o f Da ly a nd Ert i ng s hause n ( 1972) c t i on 
6 . 2 . ) . The difference in ATPase activity in the presenc e 
a nd absence of ouabain was calculated as the ouabain -
sensitive Na+,K+-ATPase activity. 
Determination of protein in the homogen ate was 
carried out according to the method of Lowry (195 1) , as 
d escr i bed i n Sec ti on 6.5. 
dup licat e . 
The en zyme activity was 
p rotein hour- 1 . 
All t e sts were done in 
expressed as mrno l P i - l mg ~ 
6. 3 . Automa t ed coupled-enz yme assa y o f Na + , K+ - ATPase 
ac tiv it y 
Reagen t s 
( A ) Basic salt so l ution 












() B ic b uff r s olu tion 
Con c e n t r atioo( mmo l / l) 
Tr i s-HCl 112 
TES-buffer 112 
pH was adjusted to 7.2 at room temperature with 
concentrated HCl (O.lmol/L). 
( C) Buffer-reagent stock solution 
O.045g disodium ATP, O.012g NADH and O.017g of 
p hosphoenolpyruvate ( PEP) and 55 ul of a commerc i a l PK / LD 
prepara t ion were dissolved in 4ml of bas i c buffer 
so l ution. 
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(D) Th \.;o r ki n g coup l e d - e n zyme r e age n t 
It was pre p a r e d by mixing 4ml o f bu ff e r - reage n t st~ 'k 
solu tion with 6ml of basic salt solution. 
The final concentrations of the different c onstitue nt s 
i n the r e action mixture were as follows: 
concentration 
NaCl 100 mmol/L 
KCl 20 mmol/L 
MgS0 4 5 mmol/L 
d i sodium ATP 3 mmol/L 
Tris- HCl 25 mmol/L 
EGTA 5 rnmol/L 
NADH 0 .5 mmol/L 
PEP 1. 2 mmol/L 
PK 1.2 U/ml 
LD 1.7 U/ml 
pH ~'" a s adjusted to 7.4 at room t emperature with 
concentrated HCl ( 0 . 1mol/L) . 
(E) Ouabain solution 
It was prepared as described in Section 6.2.(B). 
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The crude homogenate enzyme preparation was fir st 
treated with deoxycholate and sodium azide (NaN 3 ) as 
described in Sections 7.2.5. and 7.2.6. After azide 
treatment/ the homogenate was brought up to 37 0 C for 
temperature equilibrium. 100ul of the enzyme preparation 
was preincubated with and without 100ul of ouabain stock 
solution (final concentration Smmol/L) for 30 minutes at 
37°C. The Na+/K+-ATPase enzyme activity was measured by 
the decrease in absorbance of NADH at 340nm on a 
centrifugal analyser( Cobas Bio / Roche Company / Basle / 
Switzerland) . 
The Na+,K+-ATPase act ~vity was calculated as the 
difference between the ATPase activit y in the presence and 
absence of Smmol/L ouabain (final concentration) All 
measurements were done in duplicate. 
The · enzyme - activi~y. was expressed as U/mg protein. 
One unit (U) was defined as the enzyme activity which 
liberates 1.0 umole of Pi from ATP per minute at pH 7.4 at 
37°C in the presence of Na+, K+ and Mg++. 
The parameters for the automated coupled-enzyme 
reaction are given in Fig. 6.2. In each run, a commercial 
renal Na+,K+-ATPase preparation (2S0U/mg protein) was 
included as a control. 
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( 1 ) units U/ L 
( 2 ) Ca lculation factor 40 1 3 
( ] ) Standard 1 cone 0 
( 4 ) Standard 2 eone 0 
(5 ) Standard 3 cone 0 
( 6) Limit 0 
(7 ) Temperature [deg. C] 37.0 
( 8 ) Type of analysis 2 
( 9 ) Wavelength [run] 340 
(10) Sample volume [ulJ 40 
( 11) Diluent volume [ul] 50 
(12) Reagent volume [ulJ 50 
( 13 ) Incubation time [sec] 0 
(14) Start reagent volume [ul] 0 
(15) Time of f~rst reading [sec ] 300.0 
(16) r:ri:we interval [sec] 10 
(17) Number of ::-eadings JO 
( 18 ) Blanking lLlode 0 
( 19 ) Printout. wode 1 
Fig£.2. Parameters fo~ t0e automated coupled-enzyme 
assay of NaT,KT-ATPase act.ivity 
in the centrifugal anaylyser (Cobas Bioi 
Roche, switzerland) 
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. 4 . Th meas u r e me nt o f Na+ ,K+- ATPase activ it y b y 
potass ium- s timulated 3- 0 - MFPas e a ssay 
The Na+,K+ - ATPase activity of crude v a s c ul a r ( i . e . 
a orta) tissue was measured by a modif ied me th od as 
described by Huang and Askari (1975) and Norgaard et a l 
(1987) . 
Reagents 
(A) Basic medium: 






The pH was adjusted to 7.6 at 25 0 C with concentrated HCl 
( 0 . 1mol/L) . 
The 3-0-MFP was freshly disso lved and added to the basic 
medium prior to each assay. 
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D) K 1 t k s olut ion 
7 . 46g KCl was dissolve d in SOml DDW to ma k 
2mol /L KCl stock solution. 
Assay procedure 
up Cl. 
The fluorimetric assay was performed using a Hi t achi 
Spectrofluorimeter (Model. 6S0-l0M) with Xenon lamp as t he 
light source. The change in fluorescence was record ed 
continuously using a chart recorder (Graphtec SR-62 ll , 
Japan) . The excitation and emission spectrums of 3-0-
methylfluorescein phosphate were scanned. The excitation 
wavelength was set at 470nm, emission wavelength at S24nm 
and the slitwidth at Snm and lOnm respect ively. Th e 
flu orescent signal o f emission was found to be prop or-
tiona l to t h e concentration of 3-0-methylf l uoresce i n 
dissolved in the basic medium. 
SOu l of the DOe-treated crude aorta homogenate was 
added to the basic medium i n a tota l v olume of 2. 6m l at 
2S o C (i.e. room temperature). The activity before the 
addition of K+, which represents spontaneous 3-0-MFP 
hydrolysis and nonspecific phosphatase activity, was 
recorded continuously for 3-5 minutes. 13 ul of 2mol/L KCl 
was then added and the K+ -dependent phosphatase activity 
was measured for another 3-5 minutes. Based on the slopes 
of change of fluorescence, the phosphatase activity was 
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1 u l t d 
hr - 1 . 
nd xpr ssed as u mol of 3 - 0 - MFP rng - 1 pro c: i 
The p r ot e in conce ntration in the a o rt a prepara t ion 
wa s d e termined by the method of Lowry et a l ( 1951) as 
modified for the Cobas centrifugal analy s er ( viva 
i nf ra, refer to Section 6.5.). The K+-depende nt 3-0 -
MFPase activity was measured as the increase in act ivity 
caused by the addition of lOmmol/L KCl to the bas i c 
medium. 
The Na + and K+ contents of the basic medium and i n 
the react i on mixture containing the DOC-treated cr u de 
vascu l ar membrane preparations were measured b y f l a me 
photometry ( I nstrument Laboratory, IL 943, U.S.A.). - Th e 
K+ conte n t was found to be negligible i n t h em. 
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- . 5 . De t e rm i na tio n o f p r o t e in con c e nt ration 
The protein determination was done by the me thod of 
Lowr y, Rosebrough, Farr and Randall (1951) as modifi e d f or 
the centrifugal analyser (Cobas Bio, Roche Company, Basl e , 





3g/100ml Na2C03 in O.1M NaOH 
2g/100ml CuS04.5H20 
4g/100ml sodium potassium tartrate (5H 20 ) 
The working reagent was freshly prepared prior to use 
by mi xing 96 parts of reagent A wit h 2 parts of reagent B 
a nd 2 parts of reagent C. 
Work ing pheno l reagent 
This was freshly prepared prior to use by di l uting 
the stock Folin and Ciocal teau' s phenol reagent (Sigma ) 
wit h an equal volume of distilled water. 
Protein standards 
Bovine serum albumin (Sigma) at 200mg/l, 300mg/l and 
400mg/l concentrations were prepared and used as 
standards. 
Assay principle 
Tissue protein concentration was determined by t he 
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m tho of Lowry et a l (1 951 ). Th i s me thod i n v l '/ (~ '; ' 
initial ly complexing the p r otein wi t h coppe r i o n In 
an alkaline solution. In addition, the copper app earw 
t o catalyse the reduction of the phosphomolybdate or 
phosphotungstate anions in the Folin phenol reage nt, which 
is added subsequently. The latter reaction l e ads t o a 
blue colour which is measured at 750 nm. 
Assay Drocedure 
The method was modif ied and automated in a 
centrifugal analyser (Cobas Bio, Roche Company, Basle, 
Switzerland) and the parameters are listed in Fig. 6.3. 
1 0 u l of tissue homogenate sa mDle was mixed and 
i n c ubated with 300 ul of work ing reage n t at 25 0 C for 1 5 
minutes. 30 ul of working phenol reagent was then added 
into t he react i on c u rvettes and the reaction mixture was 
incubated further for 45 minutes. The absorbance of the 
reaction was read at 750 nm. The analyt i cal performance o f 
this method and the effect of deoxychloate on protein 
determination were evaluated in this study. 
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( 1 ) Unit s mg / L 
( 2 ) Calculation factor 0 
( 3 ) standard 1 cone 200 
( 4 ) standard 2 cone 300 
( 5 ) Standard 3 eone 400 
( 6 ) Limit 700 
( 7 ) Temperature [deg. c] 25.0 
( 8 ) Type of analysis 6 
( 9 ) Wavelength [nm] 750 
( 10 ) SamDle volume [ul] 10 
( 11 ) Diluent volume [ul] 20 
( 12 ) Re2.gent volume [ul] 300 
( _3 ) Incubation time [sec ] 900 
( 14 ) st2.r:: re2.gent volume [ul] 3 0 
( 15 ) rn . __ me of first. readi ng [sec ] 1.0 
( 16 ) Time . , 1 _nt.er:v2._ [see] 120 
( 2.7) NuITLber of re2.dings 18 
( _8) 31cnking moae 1 
( ~ 9 ) Prin::out moae 1 
Fig. 6.3. Parameters for the automated method of protein 
determination in the centrifugal analyser 
(Cobas Bio; Roche r Switzerland) 
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t utistica l a n a lysis 
Res ults we r e e xpres s e d as mea n ±SEM . Diff er n 
between means were tested for stati s tica l significanc e 
using the unpaired two-tailed Student's t-te s t . A l p ' 
va lue of < 0.05 was considered as significa nt, u n l ess 
otherwise stated. 
6.7. Results 
The aim of t h e present study was to compare t h e 
Na+,K+-ATPase enzyme activities of the kidney, hear t , 
l i v er, ske l eta l muscle and aorta of rats receiving salt-
loading or digoxin with untreated contro l s. T h e 
con vent iona l i norganic phosphate met hod of + + Na ,K -ATPase 
measurement was first established and evaluated for i t s 
se n s i tivit y and linearity of reaction. 
6.7.1 Evaluation of the inorganic phosphate release 
method. 
Linearity of the react i on. 
A crude renal preparation (in which Na + , K+ -ATPase 
activity is high) and a crude aorta preparation (in which 
Na+,K+-ATPase activity is low) were prepared, treated with 
deoxycholate as described in Section 7.2.5. The Na+ K+-, 
ATPase activity of the renal and aorta preparation was 
measured by the Pi release method, as described in Section 
6.2. except that the reaction was stopped after 5 mins., 
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min ...... . I 15 mins., 2 0 mins. a nd 30 min nd th o ; t [(\O I n _ 
Pi produ ced was determin e d to te s t the linearity o f th0 
r action. 
The amount of Pi released was plotted again s t time 
and is shown in Figs. 6.4. and 6.5. It could be seen that 
the reaction was linear up to 30 minutes, and this time 
was chosen in all further measurements. 
-,-T_h_e __ e_f_f_e_c_t __ o,--f __ d_e-.-,;:o_x_y*"---c_h---,o,--l--=--a_t_e _ c_o-,,-n_c_e_n_t_r_a_t_l_' -,,-o_n_-,,-o_n __ t_h_e __ N_a + ~ + =-
ATPase activity. 
Kidney and aorta preparations were treated with 
increasing concentrations of deoxycholate from 0 to 4mg 
DOC/ml (i e. o o .4% ) to study the optimal 
concentration required for activation of the sodium pump . 
The mean Na+,K+-ATPase activities plotted against the 
concentrat ~ on of deoxycholate is shown in Fig. 6.6. 
Figure 6.6. shows that the Na+,K+-ATPase activities 
were maximally acti v ated when crude renal and aorta 
preparations were treated with 0.08% deoxycholate. 
Therefore, all tissue preparations were treated with 
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Th of i norga n ic p ho s p h a t 
Na+,K+-ATPase activities of renal and aort a 
pre parations were compared, and the results are give n in 
Table 6.1. The activity of the aorta was very lov; 
(1.17 umol Pi mg- 1 protein hr-i) compared to that o f t he 
kidney (20.20 umol Pi mg- 1 protein hr-i). Renal Na + , K+-
ATPase activity was 50% of the total ATPase activity. The 
vascular Na+,K+-ATPase activity was less than 10% of the 
total ATPase activity of the preparation. 
vascular Na+,K+-ATPase activity also meant 
The low to t a l 
that even a 
slight experimental error would cause a" large error in the 
measured Na+,K+-ATPase activity. This was evident from t h e 
big standard deviat i ons and coefficients of variation ( CV) 
in vascu l ar Na + ,K+-ATPase activity. 
6.7.2. Evaluation" of the coupled-enzyme method 
In view of the inadequate sensitivity of the Pi 
release met hod to measure vascular Na+,K+-ATPase act i vit y , 
the Na + ,K+-ATPase activity of various tissues was assayed 













































































































































































































































































































Li ne ri t y o f t he r e c tion. 
To test the linearity of reaction, + + the Na ,K -ATP ao e 
activity of crude homogenates of the heart, kidney and 
liver was assayed by the coupled-enzyme method. The NADH 
oxidation was monitored from 5 mins. to 15 mins. The 
first five minutes were allowed for complete mixing of the 
samples and working reagent and temperature equilibrium in 
the centrifugal analyser. Absorbance readings were taken 
at 10-second intervals thereafter. A typical graph of 
reaction of the renal Na+,K+-ATPase is illustrated in 
Fig. 6.7. The coupled-enzyme reaction was linear from 5 
mins. up to 15 mins. and the reaction was monitored for 10 
minutes in further studies. 
The effect of varying the time of ouaba i n inhibition. 
The time required by ouabain to obtain complete 
inhibition was studied by preincubating homogenates of 
liver, heart and kidney preparations in the incubation 
buffer containing 5mrnol/L ouabain (final concentration ) 
for 30 mins. ,1 hour and 2 hours. 
activity was assayed after this preincubation. 
The results are shown in Fig. 6.8. 
ATPase activity was 124.6, 117.7 and 122.3 U (arbitrary 
units) after 30 mins., 1 hour and 2 hours of ouabain 
inhibition respectively. The result shows that 30 minutes 































































































































































































































































































































































































































i nhibit t h e tiss u e Na +,K +- ATPas e acti v i ty , 1 n ,~ 
in h ibi tion time did not further increase the Na + , K+- AT a~~ 
ac tiv i ty. A preinhibition time of 30 minut es was u sed i n 
subsequent experiments for the coupled-enzyme react i on. 
The effect of azide treatment. 
The effect of azide treatment on Na +, K+ -ATPase was 
studied by preincubating three crude homogenates and a 
commercial purified Na+,K+-ATPase preparation (Sigma 
Chemical Company) with and without 5mrnol/L sodium azide 
(final concentration) at 37 0 C. The Na+,K+-ATPase activity 
of these preparations was measured by the coupled-enzyme 
reaction and the results are shown in Fig. 6.9. -Azide 
treatment had no effect on the Na+,K+-ATPase activity of 
the purified enzyme preparation. The activities of 
Na + , K+ -ATPase in the presence and absence of azide were 
not different in the homogenates of the heart, kidney and 
liver. However, the percentage of Na+,K+-ATPase activity 
( as a percentage of total ATPase acti v ity) was higher i n 
azide pretreated homogenates. The Na+,K+-ATPase activity 
of the azide-treated kidney homogenate was 122.0 
(arbitrary) units (63%) compared to 132.3 (arbitrary) 
units (40%) in the absence of azide treatment. This 
implies that the addition of Smmol/L NaN 3 into the 
reaction system did not affect the Na+,K+-ATPase activity 





































































































































































































































































































It was d e cide d tha t homog e n a t es o f th heart , 
s kele t a l muscle and renal medulla we re to b e trea t e d with 
Smmol/L NaN 3 (final concentration) prior t o all th e 
subsequent coupled-enzyme assays. 
The effect of varying amounts of enzyme protein on Na+~+~ 
ATPase activity. 
To study the effect of the quantity of enzyme 
protein on Na+,K+-ATPase activity, different dilutions 
(and thus amounts of the enzyme protein) of liver, heart 
and kidney preparations were made and the enzyme activity 
was measured. As shown in Fig. 6 .10., the amount of 
phosphate produced increased proportionally with the 
amount of enzyme protein in the reaction system. This 
experiment gave an idea of the amount of enzyme of 
different tissue preparations to be used for the assay. 
The performance of coupled-enzyme assay. 
Na+,K+-ATPase activity of tissue preparations 
pretreated with Doe and azide were measured by the 
coupled-enzyme assay and the results are shown in Table 
6.2. The table shows that the Na+,K+-ATPase activity of 
heart, liver and kidney are high compared to aorta and the 
Na+,K+-ATPase activity in these tissues account for 30-64% 
of total ATPase activity. This shows that the difference 
between total and non-specific 'basic' ATPase activity is 



























































































































































































































































































































Th N + ,K+ - ATP se a ct i v ity o f a o rta hornog n t -· 
low a nd the difference betwee n the total ATPa se a ct i v i t y 
a nd the non-specific 'basic' Mg++-ATPase a ct i v ity i v e ry 
small. The Na+,K+-ATPase activity accounted for only 14 % 
of the total ATPase activity. Therefore, the low vascular 
Na+ ,K+-ATPase activity should be measured by a more 
sensitive method. 
The Drecision study of the coupled-enzyme assay. 
The within-run precision of the assay was determined by 
analysing 15 samples of a commercial Na+,K+-ATPase 
preparations. The between-run precision was determined by 
assaying a commercial Na + , K+ -ATPase preparation over 2-
week period . The results are given in Table 6.3. 
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6 .7 . 3. Eval u a t i on o f the K+-s timu lated 3-0- MFP 
The fl u o rime tric spe ctrum of 3-0-me thylfluo rescein. 
The kinetic fluorimetric 3-0-MFPase assay invo lves 
the measurement of the fluorescence of the fluorogen i c 
product 3-0-methylfluorescein. So, its excitation and 
emission wavelengths were first determined. To obtain the 
emission spectrum of 3-0-MF, the slitwidths and the 
excitation wavelength were fixed and the emission spectrum 
\.,;as scanned. When scanning the excitation spectrum, the 
emission wavelength was fixed. As shown in Fig. 6 .11. , 
the emission peak occurred at 525nm and excitation peak at 
470nm. Therefore, the excitation wavelength and emission 
wavelengt h were set at 470 and 525 nm respectively. 
The cal i bration curv e of 3-0-methylf 1uorescein. 
A calibration curve of 3-0-MF was prepared with each 
3-0 - MFPase assay. Standards were prepared by dissloving 
varying amounts of 3-0-MF in the basic medium that was 
used for the enzyme assay. A typical calibration curve is 
shown in Fig. 6.12. The amount of 3-0-MF released by the 
enzyme was determined from such standard curves. 
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Th li n arit y of 3-0-MFPase assay. 
The linearity of the hydrolytic r eaction was 
monitored as the change in fluorescence which was r ecorded 
continuously. One such recording is shown in Fig. 6. 13 . 
This shows the linearity of reaction with time (3 mins.) 
before and after the addition of potassium. It was 
decided to follow the reaction for 3 minutes before and 
after K+ addition in subsequent assays. 
The performance of 3-0-MFPase assay. 
The effect of potassium ion activation on the 3-0-
MFPase reaction of an aorta preparation is illustrated in 
Fig. 6.13. The K+ -dependent 3-0-t1FPase activity of th i s 
homogenate was 0.747nmol 3-0-MF mg- 1 protein min- 1 and 
-1 the total phosphatase activity was 2.697nmol 3-0-MF mg 
protein min- 1 . The K+-dependent ATPase activity was 
therefore 25% of the total ATPase activity in this 
preparation. 
The precision study. 
The within-batch precision of the assay was 
determined by assaying a homogenate of aorta 10 times. 
The coefficient of variation was 9.29%. 
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6 . 7 . 4 . EVC1 luation o f the p r ot e in d etermina t i on rn th 
The ef f ect of deoxycholate on protein det e rm ination. 
It has been reported that detergents may a ffect the 
Lowry method of protein determination (Thorne 1978 ) . An 
attempt was made to study the effect of 0.08% deoxychola te 
treatment on the protein content of tissue homogenate. A 
crude kidney homogenate (i. e. with high protein leve l s ) 
and aorta homogenate (i.e. with low protein levels) were 
assayed 10 times by the modified Lowry method as described 
in section 6.5. The same kidney and aorta preparations 
were treated with 0.08% sodium deoxycholate as described 
in Section 7.2.5. and the protein concentrations were 
reassayed. 
The results are presented in Table 6.4. It is clear 
that deoxycholate treatment at 0.08% (wjv) did not 
affect the protein determination of tissue homogenates in 
the present study. 
The analytical performance of protein determination. 
The intra- and inter-assay precision of the automated 
Lowry method was studied and the results are presented in 
Table 6.5. 
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Ti s u e h omoge n a t e 
(n= 10) 
( l \) Aorta.--
Prot e in c onc entra t i on 
(mg / L) 
Aorta- (DOC...:.treated) 
J 2 .0 _6 ±-l6-. 1 






...J l J n l [ <:.1. . r.:. (~ 
NS 
Table6.4. :The effect of deoxycholate treatment (0.08 %) on 
the protein determination. 
Values are mean±SD. 
p~;:lc ; s'o n 
H':'t~in-~un 
(n= 10) 
Bet· .. ;een -?::un 
(n=10) 
245.4::5.5 
26 1 .6::::"6. 7 
2.24 
6. 3 8 
Table 6.5.: The analytical performance of the protein 
determination method. The tissue preparation 
was assayed 10 times for precision study_ 
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DI U IO N 
In the present study, the Na+,K+ - ATPase activity of 
the crude homogenates of various tissue s and v ascu lar 
smooth muscle were measured by the phosphat e r eleas e 
method, the rate of ADP production and the 3-0-t1FPase 
reaction. It is well-known that vesicle formation of 
plasma membranes occurs 
resulting in a mixture 
during tissue homogenisation, 
of leaky and sealed vesicles. 
Various detergents at critical concentrations are used to 
acti vate the latent sodium pumps. Sodium deoxycholate was 
chosen as the detergent because its activating effect is 
less dependent on protein concentration when compared Hith 
other detergents (Jorgensen & Skou 1971). The effects of 
various concentrations of Doe were studied in the present 
study. It was found that optimal Na+,K+-ATPase activity 
occurred with a Doe concentration of 0.08%. This result 
was consistent with the findings of Jocobson et al (1980), 
Pimplikar and Kaplay (1981) and Norgaard et al (1984). 
These authors studied the ouabain-sensitive Na+,K+-ATPase 
activity at different concentrations of Doe and found that 
the specific activity of tissue Na+,K+-ATPase was highest 
at around 0.08% deoxycholate concentration. A similar Doe 
treatment protocol was used in the activation of Na+,K+-
ATPase activity in kidney and heart homogenates by others 
(Bonn & Greeff 1978; Wald et al 1985b). Hence, all crude 
tissue homogenates were treated with 0.08% Doe at 2S o e for 
30 minutes in subsequent experiments. 
96 
Usi n g t h e in o rg a n ic pho sp h a t e r e l e as e met h d , - n 
ttempt was ma d e to meas ure homog e n at e p repar a t io :::3 
ha v i n g a high Na+,K+-ATPase activity ( e.g. k idn e y 
homogenate) and a low Na+,K+-ATPase activity ( e .g. aor ta 
homogenate). In the aorta, the Na+,K+-ATPase activity wa s 
very low and accounted for less than 10% of the t otal 
ATPase activity. The low Na+,K+-ATPase activity of musc le 
homogenate is overshadowed by high nonspecific ATPase 
making its measurement by the phosphate method 
unre l iable. This method, however, is suitable f or 
measuring higher Na+,K+-ATPase activity in tissues such as 
k idney. 
An a u tomated coupled-enzyme assay was tried to 
measure the l ow vascular Na+,K+-ATPase activity. This 
me th od h as the advantage that the reaction can be 
con t inuous l y monitored and less time is required to 
meas u re a l arge batch of samples. In view of the high 
nonspecific ATPase activity present in muscle homogenates, 
samp le pretreatment · with SmM sodium azide (fina l 
concentration) was carried out. It was found that SmM 
sodium azide did not affect the Na+,K+ATPase activity but 
it reduced the nonspecific basal ATPase activity. This 
effect of azide treatment has been reported by previous 
workers. Pullman et al (1960) and Ismail-Beigi and 
Edelman (1971) have reported that Smmol/L sodium azide 
could inhibit non-ouabain inhibitable ATPase activity. Lo 
and La (1981) also included Smmal/L azide treatment when 
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r p ring crude re nal ho moge n ates . Az i d e does not - f ~c 
the PK/LD e n z ym e s y s t e m b e c a u se it i s u sed a ' d 
preserv a tive in comme rcial kit s tha t contain PK / LD a 2 
rea g e nt (Baker Centrifichem 1985). 
I n the coupled-enzyme assay, the + + Na , K -ATPase 
activity of heart, liver and kidney were 0. 1 23U/ mg 
protein, 0.09U/mg protein and 1.139U/mg prot ein 
respectively and the Na+,K+-ATPase activity was 25-60% of 
the to t a l ATPase activity. The vascular Na + , K+ -ATPase 
ac tivi t y was st i ll low and accounted for around 1 5 % of the 
total ATPase activity. Manjeet and Sim (1987) commented 
t h at an accurate and direct measurement of t h e low 
vascul ar Na + ,K +-ATPase act iv ity was dif f icult. 
A kinetic f luorimetr i c assay was used to measure t h e 
v asc ul a r Na+, K+ -ATPase activity. The coup l ed-enzyme 
me tho d was u sed t o measure the Na+,K+-ATPase activ i ty of 
ot her tissues. 
"Th e find in g t h at + + -Na , K -ATPase catalyses a 
act i vated hydrolysis of 3-0-methylfluorescein phosphate by 
Huang and Askari (1975) indicated the possibility to 
develop a fluorimetric 3-0-MFPase assay for measuring low 
Na+,K+-ATPase activity (Huang & Askari 1975,76). Hill et 
al (1968) successfully developed a highly sensitive assay 
for measuring low alkaline phosphatase activity using the 
3-0-MFP as a fluorigenic substrate. This and its recent 
app l ications to measure the Na+,K+-ATPase activity of 
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rUG homoge nates prompte d m to adopt thi~ ec hni 
m ur the v as cular Na +,K+-ATPase a c tivity . Th e obv ious 
adv a nt a ge s of kinetic fluorimetric a s say of Na+ , K+-ATPa~ 
a re its high sensitivity and specificity. Fluorimetry 
involves measurement of the emitted light, the intensity 
of which being possibly enhanced and measure d d irectly . 
The choice of measurement wavelengths and the d iffe r ent 
fluorescence spectra of individual compounds provide s a 
great degree of specif i city. Generally, the f l uore scen c e 
measurements are 100 to 1,000 times more sensi t i v e t han 
rout i ne absorption measurements (Udenfriend 1962,1969 ) . 
The excitation and emission spectrum obta i ned i n t h is 
s tudy wa s cons i st e nt with previously publ i s hed repor t s 
(N orgaard e t a l 1984,87; Horgan & Ku y pers 1 9 87 ) ; t h e 
exc itation wavelength was 470nm and emission wa v e l engt h 
S24nm. 
In the present study, the Na+, K+-ATPase act iv it y o f 
the aor ta was a lmost 1/ 4 of the total phoshatase ac t i v it y . 
Th e l arge K+-dependent fraction renders it a more accura te 
assay. To date, no one has reported the measurement of 
the vascular Na+,K+-ATPase activity by the 3-0-MFPase 
reaction. Therefore it was not possible to compare the 
results. However, Norgaard et al (1984) and Huang and 
Askari (1976) reported a similar ratio of the 
ATPase activity to the total phosphatase activity in crude 
muscle homogenates of rats and human erythroc y t es 
99 
c t i v~l y. 
This st u d y de monstrates t h at ti ss u e Na+ , K + - A TP ' e 
a ctiv ities a r e h i gh e nough to b e me as ured by the pho s phat e 
relea s e or the couple d - enzyme method. A low Na+ , K+ - ATP a se 
activity in vascula r tissues can be mea s ure d reasonabl y 
well by the fluorimetric 3-Q-MFPase assay .. 
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-'HJ\ TER 7 THE EFFE CT OF DI GOX IN TREAT~1ENT 0 I TIIr~ 
Na + ,K+ - ATPase ACTIVITY OF DIFFE RE NT TI ' U ".~ 
7.1. INTRODUCTION 
It is very well documented that cardiac glyco s ides 
+ + inhibit the Na ,K -pump. (Schatzmann 1953; Hoffman & 
Bigger 1980). The inhibitory effect of digoxin on Na+,K+-
ATPase has been demonstrated in many tissues including 
erythrocytes (Glynn 1964; Ford et al 1979a; Cumberbatch et 
a l 1981), and cardiac muscle (Gibson & Harries 1968). 
As reviewed in Section 3.5, a number of invest i gators 
have shown that when digoxin is given for long periods, 
t here is an increase in the number and activity of Na+,K+-
pumps (Israel et al 1970; Vaughan & Cook 1972; Bluschke 
et al 1976; Lindsay & Parker 1976; Bonn & Greeff 1978). 
For example, Lindsay and Parker (1976) found that chronic 
treatment of rats with digoxin produced a significant 
~ ncrease In hepatic Na+,K+-ATPase activity. In humans, 
Ford et al (1979a) reported that the erythrocyte sodium 
pump activity and intra-erythrocytic sodium content of 
patients receiving chronic treatment with digoxin did not 
differ significantly from those of a control group. It 
has been suggested that there is de novo synthesis of new 
sodium pump sites following chronic inhibition of the 
sodium pump. In this chapter the changes in tissue 
Na+ ,K+-ATPase activity of digoxin-treated rats wer e 
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~t u i - d . Th i t u y Cl l 0 r v s ClS mod 1 of corn Cl :'( I 
- r th s ub e q u e n t s t udi es o f the e f fe ct s of th e put 
n t r i u r e t i c hormon e on tis s u e Na +, K+ -ATPase acti v ity 
n a t ri uretic hormone resembl e s digitali s g lycosid e In 
biophysiological properties. 
Digoxin was chosen for the following reasons:-
( 1 ) only about 20% is protein bound in plasma, 
( 2 ) it has a high 
50 OL) , 
volume of distribution (approx . 
(3) gastro i ntes tinal absorption of 
( around 80 %), and 
digox i n is hig h 
(4) t here are well-established plasma digoxi n assays. 
The oral route of administration was used because it 
i s easier and has been used by other workers (Whittak er & 
Swa minat h a n 1 98 3 ; Kim & Gewertz 1 987), As very li ttle is 
kn own a b o u t t he digitalising doses in rats and rats are 
in sens it ive to digita l is drugs (Repke 1963), a fairly high 
oral dosage ( compared to that used in human beings ) was 
a dm i ni s t ere d t o obtain a reasonably stecdy state of plasma 
c on c ent rat i on o f di goxi n ( e.g. greater than 2.0 ng / ml) . 
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7 . ~. MATE RI AL S AND METHOD S 
7 . 2 . 1 . Animals and diets 
Adult male Sprague-Dawley rats (supplied by the An imal 
House, Chinese University of Hong Kong) weighing a b out 
300g were used. The rats had free access to standard 
laboratory Purina rat chow (composition by weight: protein 
23%, fat 4.5%, mineral 2.5% fibre 6.0% and ash 8%). 
Unless otherwise indicated, they were allowed to drink tap 
water ad libitum. 
7.2.2. Drugs 
Digoxin and propylene glycol (vehicle) were purchased 
f rom Sigma Chemical Company (st. Louis, MO, D.S. A.). 
Digoxin powder was dissolved in 40% (v/v) propylene 
glycol which was prepared by adding distilled water to 
40ml propylene glycol to make up to 100ml. 40% propylene 
g l ycol was given to control rats. 
was prepared fresh every week. 
7.2.3. Pharamacokinetics of digoxin 
The digoxin solution 
A pilot study of administration of digoxin in rats was 
carried out. A range of digoxin dosages (2.0-S.0mg Kg- 1 
day-l) were given to 3 male adult rats (digoxin group) and 
40%(v/v) propylene glycol to 3 male rats(control group) 
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r d y . 
t r mi n d 
Th post - 24 h o u r plas ma digoxin 1 v 1 'v I ~r . 
i n b oth t h e d i g o xi n a n d co n trol g roup C1::.i 
descr i b e d i n the follow i ng pharmacok i net i c s tud y . 
For the pharmacokinetic study, six mal e adult Sp rague-
Dawley rats, about 300g each, were randomly d ivide d i nto 
dig o xin group and control group. All an imals we r e 
anaesthetised with intraperitoneal inj e ction of 
pentobarbital (40mg/kg) and blood samples about 1.5ml were 
withdrawn by cardiac puncture with heparised syr i nges for 
pl as ma digoxin d etermination. 
When the animals had fully recovered, the digoxin 
group rece ived digoxin at 5mg/kg orally via a feeding 
t ube, whi l e t h e control rats received 40% ( v /v) propy lene 
g l y co l There af t er I heparinised blood samples (1. 5m l ) 
were ob tai ned at 6, 12, 18 and 24 hours after the ora l 
dose. The plasma digoxin concentrations were measured in 
du p li ca t e u s i n g a co~mercia l radioimmunoassay kit (d i gox in 
[ 12 5r J Rianen Ki t, Du Pont, U.S.A.). 
7.2.4. The Digoxin Regimes 
Rats were divided randomly into treatment and 
control groups in the three experiments. 
Experiment 1: 3-day digoxin treatment 
Digoxin (Sigma) dissolved in 40% propylene glycol 
(as vehicle) was administered orally via a gast ri c 
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f di n g tube a t Smg kg - 1 d a y - l, i n t wo di v ided O~ c; . . 
s i x r a t s (digoxin group). Six othe r rat s ( co n 1 
group) received 40% propylene glycol alon e . 
Experiment 2: 7-day digoxin treatment 
The same drug regime as the 3-day digitalisation wa s 
performed except that the treatment was continued for a 
total of 7 days in groups of 5 rats. 
Experiment 3: 3-month digoxin treatment 
Digoxin was administered at 3mg kg- 1 day-1 in two 
doses for 12 weeks to 14 rats (digoxin group) while the 
control group of 14 rats received propylene glycol. 
The animals were weighed using an electronic balance 
(Sartorius, Type 1404, Germany) before and at regular 
intervals throughout the experiment. 
At the times indicated, blood was collected into 
chilled heparinised tubes by cardiac puncture for plasma 
digoxin and electrolyte analyses. 
7 . 2.5. Preparation and deoxycholate treatment of tissue 
homogenates 
At the end of the treatment period, rats were 
sacrificed by cervical dislocation after pentobarbital 
anaesthesia (40mg/kg intraperitoneally). The heart, 
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li v r , k i dn e y, ske l e tal mu s cl e (h i nd - l i mb) a nd ortd vi ' r ~ 
q u ic kly e xci se d and kept in cold h istid i n e bu f f 
(33mmol/L histidine, 2.2mmol/L EDTA, a nd 2 80mmo l / L 
sucrose I pH 7.2). The ventricles were trans v e r sely c ut 
using an ice-cold scalpel. After decapsulation, t h e 
kidney was split longitudinally, the outer cortex was 
removed with an ice-cold scalpel and the renal medulla 
harvested. The lumen of the aorta was flushed with the 
histidine buffer using a dropper. Using a scalpel and 
forceps, the tissues were cut into fine pieces and 10ml of 
histidine buffer added to each gram of tissue. A crude 
homogenate was prepared using a Teflon-glass motor-driven 
homogeniser (Wheaton Instruments, U.S.A.) operated at 3000 
rpm for 5 strokes (10 strokes for muscle and aorta). The 
homogenization procedures were carried out at 0-4 0 C. The 
homogenate was centrifuged at BOOg for 15 minutes at 4°C 
(Jouan Centrifuge, Model CR3000 I U. S. A. ) . The resulting 
supernatant was stored frozen in small aliquots at -70 oC 
until use. 
Prior to assay, the samples were thawed and 900ul of 
EDTA-imadazole buffer (containing 22mmol/L imadazole, 
2.2rnmol/L EDTA, 0.09%(w/v) DOC and 2BOrnmol/L sucrose, pH 
7.0) at room temperature, was used to suspend 100ul of the 
crude membrane preparation. Sodium deoxycholate-
containing buffer was freshly prepared for each assay. 
The mixture was vortexed and incubated for 30 minutes in a 
shaking water bath at 25°C to achieve DOC solubilization. 
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The procedure us e d in this study i s s che matica lly s hov; 
F ig. 7.1 . 
7.2.6. Measurement of Na+,K+-ATPase activity 
To reduce nonspecific Mg++-ATPase activity, 
homogenates of heart, liver, skeletal muscle and renal 
medulla were preincubated with Smmol/L sodium azide(final 
concentration) for 30 minutes at 37 oC. 
activity of homogenates of liver, heart, skeletal muscle 
and renal medulla was determined by · the coupled-enzyme 
assay (Section 6.3.). Vascular Na+,K+-ATPase activity was 
determined by the f luorimetric 3-0-MFPase assay as 
described in Section 6.4. 
All measurements were done in duplicate. 
7.2.7. Digoxin radioimmunoassay 
The plasma digoxin levels were monitored at regular 
intervals. Plasma samples from rats of both treatment 
groups and control groups were drawn, at least 8 hours 
after the previous dose, by cardiac puncture into chilled 
heparinised tubes which were immediately centrifuged and 
the plasma stored at -20°C until analysis. 
The digoxin level was measured in 
commercial radioimmunoassay (RIA) kit 
Company, U.S.A.). In brief, SOul of 
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duplicate using a 
(Rianan, Du Pont 
plasma sample was 
An i ma l s cr i fi c e d by ce rvical d is location 
1 
aorta, heart, kidney, liver, ske l e t a l mu scle 
excised and kept in ice-cold histidine buff e r 
( 1 ) 
( 2 ) 
( 3 ) 
( 4 ) 
1 
aorta longitudinally split and flushed 
ventricle isolated from the rest of the heart 




cut into pieces with scissors and 
1 
homogenisation, (4 o C, in ice-cold 
histidine buffer (1:10 w/v) 
1 
centrifugation, 800g for 15 minutes 
1 
supernatant stored at -70 o C in 100ul aliquots 
1 
freshly thawed, addition of 
900ul deoxycholate-imadazole buffer( 0.08%, w/v) 
~ 
deoxycholate treatment, at 2S o C for 30 minutes 
J 
deoxycholate-treated enzyme preparation, ready for assay 
Fig. 7 .1. Flow diagram to illustrate the preparation of 
tissues for Na+,K+-ATPase assay 
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Onto pl stic t u be followe d by 250ul digox "n [ l /[) fJ 
tr cr . The d igoxin a nt iserum comple x sol u tion (2 Ou l , 
containing rabbit digoxin a ntibody p re-reacted with a n 
a nti serum to rabbit gamma-globulin in phosphate buff e r , 
was subsequently added. After a singl e 30-minut e 
incubation at room temperature, separation of the bound 
from free antigen was achieved by centrifugation. After 
discarding the supernatant, the digoxin-antibody comp lex 
(i.e. pellet) was counted for 1 minute in a gamma count e r 
(Packard Auto-Gamma 5780) . A standard curv e was 
constructed using known digoxin standards and the digox in 
levels of the samples were read off from the standard 
curve. 
7.2.8. Measurement of plasma electrolytes 
Plasma electrolytes were measured in an automated 
ana l yser (ASTRA 8 Beckmann Instrument, Inc . , U . S.A.), 
which uses an indirect ion-selective electrode method to 
determine sodium and potassium, the Jaffe rate method for 
creatinine and urease method for urea. 
measured in duplicate. 
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Each sample was 
7 . 3 . RESULTS 
7 .3.1. The pharmacokinetics of digoxin in the rat 
In the pilot study, it was generally observed that 
digoxin at 8 mg kg- 1 day-1 killed some rats while s ome 
rats showed toxic symptoms of vomiting and anorexia. 
When a single oral dose of 2 mg kg- 1 day-1 was given, 
the 24-hour post-dose plasma digoxin level was 1.00±0.14 
ng / ml (mean±SD; n=3). The plasma digoxin level of rats 
receiving 4, 6, 8 mg Kg- 1 day-1 digoxin respectively were 
not determined. 
In the pharmacokinetic study, the plasma concentration 
of digoxin in adult male rats as a function of time after 
oral administration of Smg/kg is shown in Fig. 7.2. 
There was a rapid decline of the digoxin level, 
probably due to efficient elimination of the drug through 
the kidney. The mean plasma digoxin level fell to 1.93 
ng/ml 24 hours after administration of digoxin. 
The half-life of digoxin calculated from the graph was 
12 hours. 
7.3.2. Plasma digoxin levels 
The results are shown in Table 7.1. After three days 
of digoxin treatment, the plasma digoxin level of the 
treatment group was 4.17 + 0.07 ng/ml (mean±SEM) and it 
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- -0 . • • The pha~~acokinetics or oral admini3~~ation o r 
digoxiLl (S mg/kg) in the rat (n=J). 




J d ays 
7 days 
3 months 





p ld~md digoxin 1 v _ 
i n rats 
(ng j ml ) . 
control digoxin-t r c 
ND 4.17 ±0 . 07 
ND J.42 ±O. S3 
ND J.82±0.57 
<0 . 0 0 
<0 . 001 
<0 . 001 
Plasma digoxin levels of control and digoxin-
treated rats after J-day and 7-day (Smg/ k g/ day 
b.d.) and J months (Jmgjkg/day b.d.) d igoxin 
treatment. 
Results are in mean±SEl1. 
ND: not detectable 
112 
wa und t ctable 1 n the control group. 
At the end of the 7-day digoxin treatment, the pl auma 
digoxin level of the treatment group in Experiment 2 
was 3.42 + 0.53 ng/ml. Rats receiving long term 
digoxin treatment in Experiment 
level of 3.82 + 0.57 ng/ml at 
period. 
3 had a plasma 
the end of the 
7.3.3. Effects of digoxin treatment on body weight 
digoxin 
3-month 
The changes in body weight of rats in Experiment 1 (3-
day digoxin treatment) is shown in Fig. 7.3. The body 
weight of the digoxin-treated rats was significantly lower 
than that of the control rats on day 1 and day 3 of 
treatment (p<O.OOS). 
The changes in body weight of the control and digoxin 
groups in Experiment 2 (7-day digoxin treatment) are shown 
in Fig. 7.4. There was an ini tial signif icant loss of 
body weight in the digoxin group (p<6.oS), but gradually 
the body weight returned to that of the control rats. No 
significant difference in body weight was observed after 7 
days of treatment between the treatment group (310.0 ± 
18.7g) and the control group (317.0 ± 9.4g). 
The changes in body weight over the three months of 
digoxin treatment in Experiment 3 are shown in Fig. 7.5. 






























































































































































































































































































































































































































































































































m- n t n ont r ol r t s f t r lon g - · m r gu z ' n 
( 5 4 3 . 2 + 2 2 . 5 g v s 5 7 4 . 7 ± 14. 5 g r ..:J p , L i J r-~ J ! ) . 
The r t of change of mean body weight o f the con tro l 
groups was calculated to be 16g/week in Exp e r i me n t 1 , 
15g/\.Jeek in Experiment 2 and 14g/week in Experime nt 3. 
There were no significant differences among the three 
control groups. 
For the digoxin-treated rats, the rate of change of 
mean body weight was 14g/week, 12. 7g/week and 11.9g/week 
in Experiments I, 2 and 3 respectively. There were no 
significant differences among the treatment groups. 
7 . 3 .4. Effects of digoxin treatment on plasma 
e l ectrolytes 
The plasma electrolyte concentrations of rats of 
Experiment 1 (i.e. 3 day digoxin treatment) are shown in 
Ta ble 7.2. Acute digoxin treatment had no effect on the 
Dlasma sodium and potassium concentrations. However, the 
plasma urea and creatinine levels were significantly lower 
in the treatment group than in the control group. Th e 
plasma urea concentration in the treatment group was 
3.7±0.Bl mrnol/L compared to 5.9 + 0.79 mrnol/L in the 
control group (P < 0.02). The plasma creatinine 
concentration of the treatment group (i.e. 23±2.9 umol / L) 
was also signif icantly lower than that of control group 
( i . e. 31 ± 6. 5 umo 1 /L) ( P < 0 . 02) . 

























































































































































































































































\.J r - no iff r n c S I n t h pla s ma s odi um a n d po r . ~;,,; i urn 
.., nc ntration s b e twee n the t r ea tme nt a n d contro l gr u ;.3 
(Table 7. 3 .). Th e plas ma urea conc e n tration of treatment 
r a ts was similar to that of the control r a t s (7 . 4 ±O.81 v s 
6.4 ±0.86 mmol/L). The plasma creatinine l e v e l of the 
digoxin group (i.e. 42±5.9 umol/L) was significantly 
higher than that of the control group (i.e. 36±2.7 umol/L ) 
(P<0.05) . 
Table 7.4. shows the plasma concentrations of 
electrolytes in the 3-month treatment group. There were 
no differences in the plasma sodium, potassium, urea and 
creatin i ne between the treatment and the control groups. 
7.3.5. 
Hear t 
Effects of digoxin 
ATPase acti v ity 
treatment on tissue N ~ + K+ -~ a. , 
The Na + , K+ -ATPase acti vi ty of ventricular muscle in 
the control and treatment groups of the three experiments 
is shown in Fig. 7.6. After 3 days of digoxin treatment, 
the Na+,K+-ATPase activity of the ventricular muscle of 
the treatment rats was significantly lower than that of 
the control group (0.111 ± 0.008 U/mg protein vs 0.153 + 
0.015 U/mg protein) (p<0.05). In rats receiving digoxin 
treatment for 7 days, the Na+,K+-ATPase activity of 
cardiac muscle was still significantly lower than that of 



























































































































































































































































































































































































































































































































. 0 U/ mg prot i n) ( p <O.O S ) . Howe v e r , In r Cl t r • 
\ .J i t 11 dig 0 x i n f o r 3 m 0 n t h s r t h e car d i a c N a + , K + - A T P a ~; (~ 
ac t i vity wa s not significantly diff e r e n t f r om tha t of th 
control rats. Comp a ring the cardi a c + + Na , K -ATP as e 
activities of the treatment group at different t imes ove r 
the entire study period, there was a significant i nc rease 
in the enzyme activity from 0.111 + 0.008 U/mg prot e i n 
after 3 days, to 0.158 ± 0.005 U/mg protein after 3 mont hs 
of digoxin treatment (P<O.OS). 
Liver 
As shown in Fig. 7.7., a similar pattern of changes 
was found in the Na+ ,K+-ATPase activity of the liver. 
Rats treated with digoxin for 3 days had significant l y 
l ower hepatic Na+,K+-ATPase compared to control rats 
( 0.063 + 0.005 U/mg protein vs 0.081 ± 0.005 U/mg protein, 
P<O.05). The inhibition ,.. +...l-or Na r K' -ATPase remained when 
rats were treated with digoxin for 7 days. However, in 
rats treated with digoxin for 3 months, the Na+,K +-ATPase 
activity of liver homogenate was not significant ly 
different from that of the control group. 
Skeletal muscle 
Fig. 7.8. shows the changes in skeletal muscle Na+,K+-
ATPase activities. Skeletal muscle Na+rK+-ATPase activity 
was lower in rats receiving digoxin for 3 days and 7 days . 



























































































































































































































































































































































































































































































































































































1 n i l nt di ff ro n c b e t we n the tre tm n oup - rJ 
n trol group was sen. 
Re n a l me dulla 
The + + Na ,K -ATPase activity in the renal medull a of 
rats receiving digoxin for different periods is s h own in 
Fig. 7.9. Rats treated with digoxin for 3 days had a 
significantly lower Na+,K+-ATPase activity than the 
control group (0.438 ± 0.011 U/mg protein vs 0.506 ± 0.020 
U/mg protein, P<0.05). This was true for rats receiving 
digoxin treatment for 7 days. Digoxin treatment for three 
mont h s resulted in no significant difference in renal 
Na + ,K+-ATPase activity between the treatment and control 
grou ps (0 .749 + 0.094U/mg protein v s 0.883 + 0.081 U/mg 
protein I p=NS). 
Aorta 
Fig ~ 7.10. shows data on the 3-O-MFPase activities of 
aorta over the three periods of digoxin treatment. Rats 
on 3-day digoxin treatment had a significantly lower 
vascular 3-0-MFPase activity compared to that of control 
rats (0.598 ± 0.026 nmol rnin- 1mg- 1 protein vs 0.727 ± 
0.045 nrnol min- 1 rng- 1 protein, P<O. 05) . A similar 
reduction of vascular 3-O-MFPase activity was found in 
rats receiving digoxin for 7 days (0.575 ± 0.054 nrnol min 


















































































































































































































































































































































































Unli k t h ot he r t iss ues , aft e r 3 - mon th digo x i n t 2 atm~r _ , 
h N + , K+ - ATP a s e a ctiv it y o f aort a was s i gn i£ic~n tl y 
lower (0.557 + 0.057nmol min - 1 mg - 1 prot e in v s 0.7 1 0 + 
0 . 04nmol min-1mg- 1 protein) (p<O.05). 
7.4. DISCUSSION 
Cardiac glycosides such as digoxin ar e po tent 
inhibitors of the sodium pump. The cardiotonic drugs bind 
directly to the Na+,K+-ATPase receptors in the heart and 
inh i bit Na+,K+-ATPase activity, thereby causing an 
inotrop ic action (Schwartz 1976). In the present study, 
digoxin was administered to rats to study the acute and 
chron i c changes of Na+,K-ATPase activity. 
Amo ng t h e digitalis group, digitoxin is ve ry long-
ac t ing, highly protein-bound (90-95%) and highl y lipid-
so l ub l e ( Goodman & Gilman 1990). Consequently, digitoxin 
is more l ikely to accumulate in fatty tissues. Ouabain 
has a s hort half-life with maximal effect at about 30 
minu tes after i njection. Digoxin is the drug of choice 
for reasons already mentioned in Section 7.1. For 
reasons of solubility, digoxin powder (Sigma Chemica l 
Company, U.S.A.) was first dissolved in 40% (v / v) 
propylene glycol. Digoxin was administered orally via a 
gastric tube to ensure an easy, safe and complete 
administration. This also provided a constant and hi g h 
rate of gastrointestinal absorption (about 60 to 80 %) 
(Sawyer, 1986) and favourable onset of action. Pre v ious 
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w rk e r h v a l so used t h is regime to admini ster igox i n to 
rats (Heinhouse et a l 1982; Saka i e t al 1 98 8 ). A ther 
we r e no ava ila ble d a t a on the LDSO and EDSO of d i g o x in 
in the rat, it was difficult to define a non- let hal a nd 
effective dose which would produce an adequat e level of 
sodium pump inhibition in vivo. 
The dose of digoxin used in the present study ~/l a s 
based on three sources of information, viz., theoretica l 
background of digoxin administration in the rat, pre v ious 
experimental regimes and a pilot pharmacokinetic study. 
The rat is resistant to cardiac glycosides because of 
the high dissociation constant of the drug-receptor 
complex (Alien and Schwartz 1969). Inhibition of Na+ K+-, 
ATPase I n rats needs drug concentrations some hundred 
times t hat required for man and dogs (Waynforth 1987). In 
general, the dosage for human is around 0.01-0.03 mg kg- 1 
day-1 (Sawyer 1986; Malini et al 1984). Ku et al (1977) 
and O'Neil et al (1984) used 0.02-0.06 mg kg- 1 day-1 
intravenuously for chronic digoxin treatment of dogs. 
Whittaker et al (1983) administered 0.04 mg kg- 1 day-1 
digoxin orally to pigs, a species very similar to human. 
Koren and MacLeod (198S) used 3 mg kg- 1 day-1 i.m. in rats 
and regarded it as a high dosage for rats. Saito et al 
(1984) found that normal mouse tolerated a single dose of 
Srng/kg digoxin intraperitonally and none died. Yasujima 
et al (1986) injected 1.2 mg kg- 1 day-l of ouabai n 
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n - r v - o u ~l y to r t s to t ud y i t s c h ro n i c - f - · () b l ( )( 
pr SS Ll r r g u l a tion a n d Strut h e r s a n d cov/ork r. -> ( 1 (8 7 
i n j ct d 1.4 mg/kg digoxin i n tra v e n ously to ra t~ . 
Re c e ntly, Kim et a l (1987) gave 3 mg kg - 1 d a y -1 digo x i n 
through a gastric tube to rats to study the ef fe c t o f 
long-term digitalisation on mesenteric haemodynamics . 
Based on these various sources of informat ion , p ilot 
experiments were carried out using a range of (relat ive to 
human dosage) high doses of digoxin (2.0-8.0 mg k g- 1 da y 
1 ) . The 2 4-hour post-dose plasma digoxin leve l wa s 
1.00± 0 . 14 ng / ml (mean±SDin=3). This confirmed t h a t a 
l arger dosage of digoxin was necessary to ac h ie v e a 
reasonable plasma digoxin level in rats (W a yn for th , 
persona l communicat i on). 
A second exper i ment on the pharmaco ki ne ti cs o f 
d igoxi n a t 5 mg kg- 1 day- l was carried out ( Fig. 7 . 2. ) . 
Oral admin i stration of d i goxin at this dosage gave a 
reasonable l eve l of plasma digoxin lev~l (i.e. 1.93 ± 0.7 7 
ng/ml , me -an ± S. D. ) . The h a lf -life of digox in was f o und 
to be 12 hours, much shorter than that in human (about 36-
40 hours). This finding was consistent with previous 
pharrnacokinetic reports in rats that the half-life of 
digoxin in the rat is shorter than that observed in man 
(Harrison & Gibaldi 1976, 1977). 
Administration of kg - 1 Smg digoxin gav e a 
reasonable level of plasma digoxin level. It was thus 
131 
~ i d to gi v e digox i n at Smg kg - 1 d a y - l i n tvlO d ' / (; ( 
dos s f o r 3 d a y s a nd 7 d a y s , and at 3mg kg - 1 day - l for 3 
mo n t hs to s tudy its acute and chronic effect s on ti --.) u 
Na + ,K+-ATPase activities. 
Three-day digoxin treatment resulted in a sign ificant 
reduction in the body weight in digoxin-treated rats. The 
body weight returned to control values when the treatme n t 
period was extended to 7 days and 3 months. The initia l 
loss of body weight was probably due to the anorex i c 
effect of digoxin. Rats ate less once digoxin treatment 
was started. Once adapted to digoxin, their food 
consumption returned to that of control rats so that long-
term digoxin treatment had no effect on body weight. Ku 
et a l (1977) and Overbeck et al(1982b) also observed an 
ini t ial drop of body weight in dogs and rats treated wit h 
high doses of digoxin. 
Digoxin treatment for various durations had no effect 
on the plasma sodium and po.tassium concentrations 
(Tables 7.2. 7 . 4. ) . The plasma urea and creatinine 
concentrations were significantly lower in rats receiving 
3-day digoxin treatment. This could be due to a rise in 
glomerular filtration rate, which might be an acute renal 
response. After 3-month digoxin treatment, the plasma 
urea and creatinine concentrations had returned to control 
values and there was no difference in plasma electrolytes 
between the control and digoxin-treated rats. These 
results in rats were in agreement with those reported by 
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1111 h ~l ( 19 81) who f ound n o ff ct i lon r - L(~.r Ir\ 
l x i n tr tme nt on plasma e l e ctrolytes i n ma n. 
Th e pl a sma l e vel of digoxin was ma in t ai n e d t 0 
reasonable level throughout the treatment p e r iod. The 
reduction of Na+,K+-ATPase activities of various t is sues 
receiving digoxin treatment for 3 days indicated that t he 
dosage used in the present study was effective to produc e 
an adequate and constant level of Na+,K+-ATPase inhibition 
in vi vo. 
As anticipated, the tissue Na+,K+-ATPase activities 
of rats receiving digoxin for 3 and 7 days were lower. 
Such short-term effects of digoxin were also reported by 
prevlous workers. Ford et al (1979a&b) reported that 
d u r i n g the fir s t se ve r aid a y s 0 f a dm in i s t rat ion 0 f 
digoxin, erythrocyte 86 Rb uptake and 3H-ouabain binding 
were lower and intracellular sodium concentration was 
higher in the erythrocytes. Boon et al (1986) further 
demonstrated a reduction in the in vivo Na+,K+-ATPase 
ac~ iv ity in patients who had been taking digoxin for less 
than ten days. A reduction of Na+,K+-ATPase was also seen 
in the myocardial tissues of guinea pigs (Bluschke et al 
1976) and dogs (Ku et al 1977) receiving digitalis 
treatment for less than 7 days' duration. struthers et al 
(1987) also demonstrated a decrease in 42K uptake in the 
ventricles and lungs of rats receiving digoxin infusion 
for several hours. 
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A - r t h r mo n t h s o f treatm e nt , th r v.l r(~ I) 
ign ific n t d iff re nces i n the Na +,K+- ATP ase acti v it i ~ ( 
t he live r, kidney, heart and skeletal mu s cl e . Thi s me a nt 
that the inhibitory action of digoxin did not p e r sist wh e n 
the drug was given for a longer time. This could b e due 
to a compensatory increase in the Na+,K+-ATPase act ivit ies 
in these tissues. 
Previous longitudinal studies have shown that the 
inhibi tory effect of digoxin did not persist upon 
term treatment. Ford et al (1979a&b) demonstrated 
long-
that 
the erythrocyte 3H-ouabain binding and intracellular 
sodium returned to control values in patients receiving 
d i goxi n treatment over three months. Morgan et al (1980) 
a l so reported that there was no apparent difference in the 
ery throcyte sodium content in patients receiving digoxin 
for more than two months when compared to that of \vell-
matched control subjects. Whittaker et al (1982) reported 
in pigs treated with digoxin for 14 weeks that the red 
ce l l sodium returned to control values. Boon et al (1986 ) 
studied the in vivo sodium pump activity by measuring the 
changes in plasma and red cell rubidium concentration 
following an oral load of rubidium chloride. They found 
that there was no significant difference in the in vivo 
sodium pump activity between patients receiving long-term 
digoxin therapy (3 months) and their respective controls. 
Thus, chronic treatment of digoxin does not exert an 
inhibitory effect on Na+,K+-ATPase activity. Boon et a l 
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n d I' ord t al (1 9 7 9 b) s ugg st)d h 
in h i b itory e ff e ct of digoxin on th e + + Na , K - AT P a~~ 
a ctiviti e s may be subjected to pharmacological tol r a nc e . 
This could be due to a compensatory increas e in the number 
of membrane-bound sodium pump sites. 
The compensatory increase in the sodium pump activi ty 
was demonstrated more clearly by other workers. An 
increase in myocardial Na+,K+-ATPase activity was shown i n 
guinea-pigs treated with digitoxin (0.3 mg/kg s.c.) for 24 
days (Bluschke et al 1976; Bonn & Greeff 1978 ) . 
Similarly, an increase was seen in hepatic Na+,K+-ATPase 
activity in rats receiving chronic digoxin treatment for 
45 days (Lindsay & Parker 1976) and in erythrocyte Na+,K+-
ATPase activity in pigs receiving digoxin for 14 weeks 
(Whittaker et al 1982). 
The mechanisms of the increase in Na + , K+ -ATPase 
activity may be due to an increase in the amount of pump 
sites (de novo synthesis of new Na+,K+-ATPase molecules) 
or an alteration of the specific properties of the enzyme 
molecules (e.g. Kd). Bluschke et al (1976) and Bonn and 
Greef (1978) found that there was no change in the 
specific kinetic properties (e.g. Kd) of the Na+,K+-ATPase 
associated with the compensatory increase in myocardial 
For instance, Bonn and 
Greeff (1978) showed a similar concentration for half-
maximal inhibition (=10- 6M) of digitoxin in enzyme 
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p r from di g itox i n - trea t d a nd c on trol a n : rn - l ~.; . 
K o f u b i n - e n z yme - comp l e x of bo th e n z ym 
hlld n ear ly th e same value ( =1. 8x10 - 7 M) . En z ym from 
control a nd that from the digitoxin - trea t e d anima l s shoTdE.d 
no alteration in the pH optimum of the ATPase activity _ 
The Michaelis-Menten constant (Km) for ATP wa s no t 
significantly altered as a result of chronic treatment 
with digitoxin. This kinetic study suggests that t he 
adaptive response of Na+,K+-ATPase activity to chronic 
inhibition may be due to an increase in the number of 
enzyme pump sites (Bonn & Greeff, 1978). 
studies using several types of cultured cells have 
demonstrated that the adaptive response of Na+,K+-ATPase 
after chronic inhibi tion by digoxin was due to de no v o 
synthesis of new pumps (Section 3.5.). Vaughan and Coo k 
(1972) and Boardman et al (1974) showed that the increase 
in 3H-ouabain binding following exposure of HeLa cells to 
20nM ouabain for 24 hours was abolished by cycloheximide 
and puromycin, suggesting that protein synthesis of pump 
sites was indeed involved. In isolated human HeLa cells, 
Lindsay (1974) found a significant increase of 
ATPase activity after chronic incubation in ethanol 
(43.3rnM) which was prevented by cycloheximide. 
The changes in the Na+,K+-ATPase activities of heart, 
liver, skeletal muscle and kidney in Experiments 1, 2 and 
3 showed that there was a gradual increase in the Na+,K+-
ATPase activity over the period of digoxin treatment. The 
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ctiv i t i e s o f variou s ti s u s o f h c 
gro u ps we r e simi l a r i n all three exp e rim e n t ~ . Th ~ ~ 0 
a lt e r a tions are in a direction which i s co nsist e nt wi t h a n 
adaptive compe nsation of the Na+,K+ - ATPase a c tiviti es i n 
these tissues. 
In contrast to the present finding of adapt ive 
response and the findings of Bonn and Greeff (1978) and 
Bluschke et al (1976), Ku and coworkers (1977) showed no 
change in myocardial Na+,K+-ATPase activity and digoxin 
binding sites in dogs treated with digoxin (8-12 ng/kg 
i. v.) for up to one month. · There are several possible 
reasons for this discrepancy. The difference in results 
may be due to the difference in the animal species 
employed. The duration of digoxin treatment between t h e 
present study and that of Ku et al (1977) is also 
different. Rats were treated for three months wit h 
digoxin in this study whereas Ku et al administered 
digoxin to dogs for only one month. Previous 
investigators clearly showed the importance of the 
duration of the glycoside treatment. Bonn and Greeff 
(1978) and Bluschke et al (1976) showed increased 
myocardial Na+,K+-ATPase activity following digoxin 
treatment for 24 days. Ford et al (1979b) demonstrated 
the reversion of erythrocyte sodium pump activity to 
control values in patients during chronic digoxin 
treatment. Swaminathan and coworkers showed a significant 
increase in erythrocyte Na + , K+ -ATPase acti vi ty after 2 9 
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111 nths o f digox i n trea tme nt i n ma n ( Cumbe rba t c h __ 1_ 1 ( 1 ) 
~ nd aft e r three months ' in porcine e ryth r ocytes (Vlhittak 
et a l 1983). In rats, an increase in hepatic Na+ , K+-ATP a 
activity was seen after 45 days of digox i n tre a t ment 
(Lindsay & Parker 1976). The short period (on e mon t h ) o f 
digoxin treatment used by Ku and coworkers (1977) mi g ht 
explain their negative findings. 
In the present study, the adaptive regeneration wa s 
not demonstrated in Na+,K+-ATPase activity of the aorta; 
the inhibitory effect of digoxin persisted after 3 mont h s 
of treatment. One possible explanation was that different 
tissues have different rates of turnover of new pump 
sites; the vascular tissue may have a slower rate so that 
i t may t ake longer to regenerate new Na+,K+-ATPase 
molecu l es. 
I t is poss i ble that the adaptive response of Na + ,K+-
ATPase of the aorta might have been shown if the duration 
of digoxin treatment had been longer. This is the reason 
why t he effect of digoxin-like natriuretic hormone on 
tissue and vascular Na+,K+-ATPase activity was studied up 
to one year in the subsequent salt-loading experiment 
(Chapter 8). 
Despite the failure to demonstrate an adaptive 
response in Na+,K+-ATPase activity of the aorta, possibly 
due to a slower rate of de novo synthesis of new pump 
sites and slower dissociation of the digoxin-en z ym e 
138 
mpl X, t h p r s n t s tu d Y i s i n a 9 r e e m e n t vJ i h P r ~ / j U ; ; 
findi n g nd s ugges t s tha t chronic i nh ibition o f 
ATPase by digoxin may result in an ada p t ive r es ponse i n 
the en z yme activity. 
In order to clarify whether chronic inhibition of 
tissue and vascular Na + ,K+ -ATPase may result in a 
compensatory response, a similar model of inhibition of 
Na + 1 K+ -ATPase by the endogenous digoxin-like na triuretic 
hormone was examined over a longer period of time in the 
salt-loading experiments i.e. Chapter 8. 
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HA 1'ER TH E SALT- LOADI NG EXPERIM ENT 
8 . 1 . I NTRODUCT I ON 
There are many experimental mano e u v r es to indu c e 
volume-expanded hypertension in animals. These include 
renal artery occlusion or ligation (i. e. Goldblatt 
Hypertension), infusion of renin and angiotensin, DOCA and 
salt supplements after nephrectomy (Gavras et al 1 975 ) , 
a nd high salt intak e (Dahl et al 1962). Salt-load i ng i s 
t h e mos t c ommon ly employed and simplest method becau se i t 
does n ot i n volve pharmacological or surgica l 
in ter v e nti ons . 
c hro n i c ally fed 
hyp er ten s ion . 
Earlier work has shown t h at rats 
on a 







de v e l ope d 
in duce d 
hyperten s i on in rats by mix i ng NaCl with t heir food and 
a ll owing ad l i bi tum consumption of both food and water. 
Da hl e t al (1 962 ) reported wi th substantia l evidence that 
a h igh di e t ary i ntake of NaCl alone induced permanent 
hyper t e n s i on in rats. A positive relat i onship betwee n 
dietary sodium intake and high blood pressure was also 
s hown in the INTERSALT study (Section 2.1.1.). All these 
experimental results supported that excessive salt intake 
may induce hypertension. 
An increasing level of a digitalis-like humora l 
factor(s) has been found in response to volume expansion 
i n animals (Haddy & Overbeck 1976; Gonick et al 19 77; 
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r --.t a l 18 0; Ha ml yn ~ 1 1 8 2-, 1 I I n Cl ((.: /. 
r i n 1984 ) _ Thi s humo r a l n a tr i u r etic ho rn( [} (~ 
inhibits the sodium pump in vivo, r e sul ting i n a n i n cre - ~ J 
in p e riphe ral r e sistance(Section 2.3.). 
Chronic inhibi tion of Na + ,K+ -ATPase, however, in a 
range of cell types was found to elicit a cellu lar 
homeostatic response in which Na+,K+-ATPase activ i ty 
increased to restore the intracellular milieu toward the 
pre-inhibition level (Section 3.5.2. and Section 3.6.2. ) . 
Thus chronic inhibition of vascular Na+,K+-ATPase activity 
may produce only transient elevation of free cytosolic 
calcium ion levels and only transient hypertension. 
Therefore, it is important to investigate the consequences 
of chron ic salt-loading on Na+,K+-ATPase activ i ty. 
I n the present experiments, rats were fed with high 
sa l t intake for 1 week, 3 months and over one year. The 
pattern of changes in the Na+ ,K+ -ATPase activity in the 
cells of different tissues was studied. The objective is 
to test whether chronic inhibition of the sodium pump may 
result in an adaptive response in its activity. 
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~\TERI ALS AND METHODS 
8 . 2 .1. Animals 
In all the studies, adult male Sprague-Dawley rat s 
of about 8 to 10 weeks of age weighing 250-300g were 
used. The animals were kept in plastic cages (5 
rats/cage) at room temperature of 22±1 °c. They had free 
access to standard laboratory rat chow (Rodent Laboratory 
Chow 5001, Purina Mills Inc.; composition by weight is as 
follows: protein 23%, fat 4.5%, fibre 6%, ash 8%, mineral 
2.5%) and unless otherwise indicated, they were allowed to 
drink tap water ad libitum. 
8.2.2. The salt-loading protocol 
Rats were randomly divided into the experimental and 
control groups. They were maintained on one of the 
following regimens. 
Experiment 1 Short-term salt-loading experiment: 
Seven rats were fed on standard Purina Chow plus 1.8% 
saline (NaCl) solution as drinking water for 7 days. A 
control group of 7 rats were given tap water and received 
the same diet. 
Experiment 2 Medium-term salt-loading experiment: 
Fourteen rats were given normal Purina Chow with 1.8% 
saline solution to drink for three months. The control 
group(n=14) was given tap water. 
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·x rim nt 3 Long - t rm salt - l o a d i n g e xperim n t : 
R t were gi v e n 1 . 8% sa l i n e solut i on a ' d ri nk ' n g 
\.Ja ter fo r on e y ear . The control rat s were give n t ap 
wa t er . There were 11 rats in each group . 
All drinking solutions were administered ad libi tum. 
During the study period, the rats were weighed in t he 
morning wi th an electronic beam balance. When dai ly 
urinary sodium excretion was to be assessed, bot h 
experimental and control rats were put into metabol i c 
cages 2 4 hours prior to urine collection. The second 24-
hour urine sample was collected and the volume measured 
using a measuring cylinder. 
stored at -20 0 C in a clean 
ur inary electrolyte analysis. 
An aliquot of each sample was 
plastic tube for subsequent 
8.2.3. Preparation of crude tissue homogenates 
At the end of the salt-loading period, both 
experimental and control rats were sacrificed by cerv ica l 
dislocation. The left ventricle, liver, left kidne y , 
hind-limb skeletal muscle and aorta were immediately 
removed from the stunned rats. The organs were 
immediately chilled on ice and dissected free of attached 
connective tissue. The tissues were then homogenised, and 
treated with deoxycholate as described in Section 7.2.5. 
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. ~.4 . M s u reme nt of Na+ ,K+ - ATPase activity 
Th Na +,K+ - ATPase activity o f cr u de me mbr n J 
pre p a r a tion of the liver, renal medulla, s k e l etal muscl 
and heart was determined by the method of coupl e d- e n zyrn e 
assay as described in Section 6.3. The rate of oxida t ion 
of NADH was measured by the decrease in the absorbance o f 
NADH at 340nm. 
The vascular (aorta) Na+,K+-ATPase activity was 
measured by the fluorescent 3-0-MFPase assay as described 
in Section 6.4. 
8. 2. 5. Analysis of urinary electrolytes 
After collection, urinary samples of both salt-loaded 
a nd control rats were measured simultaneously for urinary 
e l ectro l ytes in the Astra-8 autoanalyser (Beckmann 
Instrument, Inc. I U.S.A.). 
Urinary sodium was assayed by the indirect ion-
se l ective elect r ode, and creatinine determined by the 
Jaffe rate method. Each sample was measured in 
duplicate. 
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M s u r me n ts o f body weight a nd orga n w t w "g h 
I n Exp e rime nt 1, the whole left k idney was qu ick l y 
e xcised from control and salt-loaded rat s , b lotted dry and 
weighed on the day of sacrifice. 
The salt-loaded and control rats were weighed using an 
electronic balance (Sartorius, Type 1404, Germany) before 
and at regular intervals throughout the experiments. 
8 . 3 . RESULTS 
8.3.1. Effect of salt loading on the body weight of rats 
The changes in body weight in the rats in Experiment 
1 i s shown in Fig. 8 .1. The mean body weight of sal t-
l oaded group was higher, though not statistically 
significant, than that of the control group a t day 7 
(3S0.7±8.1g vs 335.7±7.4g, mean±SEM). After 12 weeks of 
high sodium intake (Fig. 8.2.), the body weight in the 
salt-loaded rats was significantly lower (47S . 1±21.8g; 
n=13) than that in the control rats (598.8± l S.9g; n=1 4) 
(p<O.OS). From Fig. 8.2., it is evident that while the 
control rats were gaining weight over time, the mean body 
weight of salt-loaded rats began to level off after eight 
weeks of salt loading. 
Experimental rats receiving salt loading chronically 
over one year became very thin. The mean body weight of 
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(m n ±SE M) a n d s igni fi c a n t ly low e r th n th a o £ - r (.: 
ont r ol group ( 5 43.7 ±22 .0g) (p<O.OOl) ( Fig . B . 3 . ). 
8.3.2. Effects of salt loading on 24-hour urina ry sod ium 
excretion. 
The effect of salt loading on urinary sod i u m 
excretion is shown in Table 8.1. The urinary sodium 
excretion in the experimental group was higher in 
Experiment 1. The mean daily urinary sodium excretion of 
the experimental group was 16.6±3.3 mmol Na/24 hours 
(n=5) (mean±SEM) compared to 1. 9±O.1 mmol Na/24 hours of 
the control group(n=5) (p<O.OOOl). 
Rats (n=13) receiving three months of salt loading 
continued to excrete more sodium and had a daily urinary 
sodium excretion of 27. 0±2.1 mmol Na/24 hours (mean±SEM) 
whereas the daily urinary sodium excretion of the control 
group (n=15) remained at 1 . 9 ± 0 . 2 mm 0 1 N a / 2 4 h 0 u r s , 
(p<O.OOl). The urinary sodium excretion became fairly 
constant after about eight weeks of salt loading (Fig. 
8 . 4. ) . 
In Experiment 3, the urinary sodium excretion of the 
experimental group (n=ll) was 27.2±2.4mmol Na/24 hours and 
was significantly higher than the 1.6±O.1 mmol Na/24 hours 
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Eff c t s of s a l t - loa ding on t h 
k i n e y 
v.; vI . i 
As shown in Figure 8.5., there was n o sign ifi cant 
diff e rence in the wet weight of kidney of s alt - l oade d and 
control rats. 
8.3.4. The effects of salt loading on tissue Na+ K+-, 
ATPase activity 
Heart 
The Na+,K+-ATPase activity of the heart in the three 
experiments is shown in Fig. 8.6. In the short-term sa l t 
loading experiment (i.e. 7 days) , the cardiac 
ATPase activity of the salt-loaded rats did not differ 
from that of control rats (0.135±0.002 U/mg protein vs 
0. 1 36±0.OOB U/mg protein; n=12). 
After three months of salt loading, there was still 
no significant difference in the cardiac Na+,K+-ATPase 
activity between the salt loading group and control group. 
The mean cardiac Na+,K+-ATPase activity of the treatment 
group was O. 145±O. 005 U/rng protein, slightly higher than 
that of the control group, which was O. 141±0. 005 U/mg 
protein (n=13). 
When rats were chronically salt-loaded over one year, 
the cardiac Na+,K+-ATPase activity was found to be higher 
(0.155±0.004 U/rng protein; n=ll) compared to that of the 
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Liv - r 
The e ff e cts of salt loading on Na+,K+ - ATPase activ it y 
of the liver is shown in Fig. 8.7. After short t e rrn ( i . e . 
1 week) salt loading, there was no significant difference 
in hepatic Na+,K+-ATPase activity between the treatment 
group (0. 088±0. 004 U/mg protein; n=12) and the control 
group (0.086±0.003 U/mg protein; n=12). 
In rats salt-loaded for three months, the hepatic 
Na+,K+-ATPase activity was significantly higher when 
compared to that of control animals (0.090±0.00s U/mg 
protein vs 0.07s±0.004 U/mg protein) (p<O.OS). 
Hepatic Na+ ,K+ -ATPase activity in the i-year salt-
loaded group (0.092±0.006 U/mg protein; n=7) was 
significantly higher compared to that of the control group 
(0.062±0.007 U/mg protein; n=11) (P < 0.05). These 
results indicated that when rats were chronically salt-
loaded for three months or more, the hepatic Na+,K+-ATPase 
activity was significantly enhanced. 
Skeletal muscle 
The pattern of changes of skeletal muscle Na+ K+-, 
ATPase of salt-loaded rats in the three experiments (7 
days, 3 months and over one year) is shown in Fig. 8.8. 
Rats receiving 1.8% saline for 7 days had a skeletal 





















































































































































































































































































































































\,.1 1 i h \ ,.1 n t i 9 n i f i c II n t 1 Y d i f f e r n t fro m 1 ( ~ 
nt 1 group ( 0. 026± 0 . 00 3 V/mg protein). 
Wh e n rats (n =1 0) we r e s alt-loa d ed for th ree mon th s , 
it wa s f ound that the skeletal musc le Na+ I K+ - ATPa se 
a ctivity was slightly and not significantly i nc reased in 
compa ri s on with that of the control group (0 . 028±0. 004 
U/ mg protein vs 0.026±0.002 U/mg protein). 
In rats receiving long-term salt loading (i. e. o ne 
year ) , t here was a significant increase in the s k eleta l 
mu sc l e Na + , K+ - ATP ase activity compared to t hat o f the 
contro l group (0.047±0.007 U/mg protein vs 0.029±0. 0 0S 
U/mg p r ot e i n ) (P<O.OS). 
Re nal medull a 
Figure 8. 9 . shows the effects of sal t l oading o n 
re n a l me dullary Na+,K+-ATPase activity. Even after 7 days 
of sa lt l oading, the renal Na+,K+-ATPase activit y was 
f ou nd t o be signi fi cantly h i gher than that of t h e controls 
(0 . 962 ±0 .06 0 U/mg protein v s 0.71 2± 0.020 U/mg p rote in ) 
(p<O.OS) . 
When rats were salt-loaded for three months, the 
renal Na+,K+-ATPase activity (1.097±0.OSO U/mg protein; 
n=ll) was signif icantly higher than that of the control 
group (O.924±0.037 U/mg protein; n=13) (p<O.OS). 
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h ro n ic s a lt lo a d i n g o f r a t s for ov e r 
r s u i ted i n a s i gni fi c a ntly highe r r e nal med u ll a ry N + / K~ -
ATPa s e a ctivity (p<O.005). 
activity of salt-loaded rats was 1.427±O.050 U/mg pro t e in 
(n=ll) whereas that of control rats was 1.079±O.038 U/mg 
protein (n=7). 
These results suggested that the renal medullar y 
Na+, K+ -ATPase activity was increased after salt loading 
for one week or longer. 
Aorta 
The Na+,K+-ATPase activities of aorta from salt-
l oaded a nd control rats were determined by the 3-0-MFPase 
acti v it y and are shown in Fig. 8.10. Short-term salt 
l oading (i.e. 7 days) had no effect on aortic 3-0-MFPase 
activity. The aortic 3-0-MFPase activity of the salt 
loaded group was O.700±0.030 nmol 3-0-MF min- 1 mg- 1 
protein( n=5) whereas that of the control group was 
O.591±O.053nmol 3-0-MF min- 1 mg- 1 protein (n=5). 
When salt loading was extended to three months, the 
3-0-MFPase activity of the aorta did not change. The 
aorta 3-0-MFPase activity of salt-loaded rats was found 
to be O.661±O.061 nmol 3-0-MF min- 1 mg- 1 protein (n=8) 
compared to O.675±O.069 nmol 3-0-MF min- 1 mg- 1 protein of 















































































































































































































































































































































































































A sign ific n t i nc rease in 3 - 0 - MFP as act i / i - y CJ 
aorta was f ound whe n r a ts we re chron ica lly f e d on high 
sa lt int a k e for one year. The aortic 3- 0-MFPase ac tiv it y 
of one-year salt-loaded rats was found to be 1.047 ±O . OS2 
nrnol 3-0-MF rnin- 1 rng- 1 protein (n=11), and was 
significantly higher than 
(O.703±O.029 nrnol 3-0-MF 
(p<O.OOl). 
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that of the control 
rnin- 1 rng- 1 protein; 
gro up 
n=11 ) 
8 .4. DIS USSI ON 
It has been proposed that extracellular flu id volume 
expansion may result in the release of a c ir c ul ating 
natriuretic factor which inhibits the Na+,K+ pump (S e c ti o n 
2 .3 . ) . It was further suggested that this inhibition of 
the sodium pump results in vasoconstriction of arteriola r 
smooth muscle and so leads to systemic hypertension (Haddy 
& Overbeck 1976; Hamyln et al 1982). These concepts I if 
proven, may help to explain the relationship between 
excess salt intake, extracellular fluid volume expansion 
and blood pressure. Previous workers have described an 
inhibition of Na+,K+-ATPase activity in various forms of 
experimental hypertension characterised by volume 
expansion (Gonick et al 1977; Gruber et al 1980; 
DeWardener & MacGregor 1980a&b). Unfortunately, most of 
these models employed various other manoeuvres (e. g. 
partial nephrectomy, administration of DOCA) in addition 
to high salt intake and ' .... l l. is not clear whether the 
observ ed i n h i b i ti o n o f Na+, l< +-ATPase was the result of 
volume expansion alone or not. Moreover, De Mendonca et 
al (1983) showed no effect of high salt intake on the 
ouabain-sensitive sodium (22Na) efflux in rat erythrocytes 
whereas Gudmundson (1984) found an increased sodium (22Na) 
efflux of red cells in man with increased salt intake. 
Because of these conflicting results, the examination of 
the effect of a high salt intake alone on the tissue 
Na+,K+-ATPase activity in rats is necessary. 
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I n t h present s tudy, i t was foun d t hat .-J hor - :: _frt 
it loa di n g d i d not c a us e a s igni fica n t cha n g e i n the 
body \.J e ight of rat s . Wald et al (198 3 ) a nd Va s d e v ~ -1 
(1988) also found no difference in the body weight of r at s 
salt-loaded for 12 days or 30 days. Long t e rm salt 
loading (e.g. 3 months and 1 year), however, resul t ed in a 
signif icant reduction in body weight. This finding is 
consistent with that of previous workers (Wanquier & 
Devynck 1989). The fall in body weight is probably due to 
a decrease in lean body mass, as chronically salt-loaded 
rats were very thin and ate less. No difference in the 
wet weight of organs (e.g. kidney) was observed on the day 
of sacrifice. 
sa l t intak e during the study periods was estimated b y 
measur ing t he 24-hour urinary sodium excret i on. Rats 
receiving 7 days, 3 months and one year salt l oading had a 
signif i cant ly higher daily sodium excretion than their 
resDect ive control rats. The highly signif icant sodium 
in t a Ke a s re i le c t ed b y t he 
would lead to ECFV expansion. 
renin activity could be of 
expansion. 
urinary sod i um excret i o n 
Measurement of the plasma 
value to indicate ECFV 
The Na+,K+-ATPase activities 
skeletal muscle and aorta were not 
loaded for 7 days and 3 months. 
of the heart, liver, 
reduced in rats salt 
These results were 
consistent with several previously published studie s. 
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w nn ( 1 85 ) d e mon s tra t e d tha t t her wa no if f r An ( ~ J n 
+ + the Na ,K - ATP a s e activity of th e h eart a n d c er b - 1 
c orte x o f rats receiving four weeks of h i gh sal t intake . 
Bradlaugh e t al (1987) also demonstrated no diff e r e n ce in 
the aortic smooth muscle 22Na efflux in normal rats f ed 
a high salt diet (1.5% NaCl for 1 month). 
It is interesting to note that the Na+,K+-ATPase 
activity of all the tissues (except liver and renal 
medulla) in rats receiving high salt intake for 7 days and 
3 months was not different from that of the controls. If 
volume expansion causes the release of digoxin-like 
substance, it would be expected to cause a reduction in 
Na+,K+-ATPase activity. There may be several explanations 
for this. There may be no digoxin-like natriuretic factor 
induced by the acute salt loading. However, t h is 
possibility is unlikely as there is strong experimental 
evidence that both acute and chronic salt loading in 
humans and rats induce the release of an endogenous 
sodium pump inhibitor (Gonick et al 1977; DeWardener et al 
1981; Hernandez & Godfraind 1984; Devynck et al 1984b; 
Goto et al 1989). It is possible that the level of NH was 
not very high due to only a moderate or small degree of 
ECFV expansion. Wauquier and Devynck (1986, 1989) studied 
the plasma digitalis-like activity in rats during chronic 
sa it loading. Their results showed that the plasma 
digitalis-like activity gradually rose wi th time. For 
instance, the plasma apparent digoxin concentration, 
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c lc u lat d fr om its cross- r eactiv it y with n t i l j Z lfl 
a n ti bodies , wa s s ignific a ntly increased o n ly aft er 13 
weeks of high salt diet. So, after 7 d a y s and 3 month s o f 
high salt intake, the level of NH induced, if any, may no t 
be high enough to exert a marked inhibitory effect. 
Another possible explanation is that this endogenou s 
inhibitor dissociates from the sodium pump receptor during 
the in vi tro manipulation of the tissues. Several 
previous workers have suggested that the endogenous 
natriuretic factor might e~sily be washed away during 
experimental procedures (Overbeck & Grissette 1982a; De 
Wardener and Clarkson 1982; Sierra et al 1988) so that 
the enzyme inhibition in vivo was not apparent in vitro. 
Overbeck and Grissette (1982a) found an increased activity 
of the sodium pump in arterial muscle in vi tro. In 
contrast to this finding, a decreased pump activity i n 
vivo in arterial smooth muscle was found in rats with the 
same form of volume-dependent Goldblatt hypertension 
(Overbeck et a l 1976 ) . They pointed out that it was 
like l y that the circulating digitalis-like inhibitor 
dissociates extremely rapidly from the pump molecules in 
vitro in rats, a species relatively insensitive to 
digitalis To explain the discrepant findings in the 
activity of the sodium pump in various models of 
hypertension, Sierra et al (1988) pointed out that cells 
and tissues from hypertensive subjects could manifest 
either increased, unchanged or decreased activity o f 
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di um pump d e p e nd i n g upon whe the r the e nd o genou 
diss o c i a t e d from the pump during ti s s u e pre p a r ation 0 ' [ 
the r e i s compensatory increase in the number o f pump unit ~ 
when the pump is chronically inhibited. Bradlaugh et al 
(1987) found no difference in aortic sodium pump activ i ty 
between salt-loaded and control rats and suggested that 
the proposed circulating NH had been washed off during 
tissue preparation. 
To date, there has been no study on the stability of 
the NH- Na+,K+-ATPase complex in rats. As the preparation 
of various tissue homogenates in this study involved 
dilution, vigorous homogenisation and centrifugation, one 
would expect that all of the most rapidly dissociating and 
most of the slowly dissociating NH-Na+,K+-ATPase complexes 
wou l d ha v e dissociated. This would explain why there were 
no differe n ces in the tissue Na+,K+-ATPase activity of 
rats salt loaded for 7 days or 3 months. 
To 'verify whether the NH is present and whether there 
is i n vivo inhibit ion of t he pump af te rei the r acute 0 r 
chronic salt loading, the sodium pump activity can be 
measured directly by the in vivo Rb uptake technique 
(Section 5.2.1.). Boon and coworkers (1984b) first 
advocated the use of in vivo measurement of cation 
transport activity to prevent in vitro artefacts. 
In contrast to these present findings of short-term 
salt loading experiments, Weissberg et al (1984) and Boero 
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~ l ( 1985 ) both d e mon strated a dim i n ish QUClb - in 
s nsitive 22 Na eff lux in the e rythrocytes of norm 1 h urn -
subjec ts after acute saline infusion. Quintanill a 
(1988) detected reduced erythrocyte + + Na ,K -ATPas e 
activity in normotensive men given a high salt diet for 5 
days. This discrepancey could be due to a difference in 
the animal species used, the cell type studied, or the 
assay methods employed. For example, the reduction in 
Na+ ,K+-ATPase activity found in the above-mentioned 
studies was in the erythrocytes which are anucleated and 
intravascular wherea.s nucleated and extravascular cells 
were studied here. The lack of difference in the Na+ K+-, 
ATPase acti vi ty of heart, cerebral cortex and aortic 
smooth muscle of rats given high salt diet (1.5% NaCl for 
one month) by Swann (1985) and Bradlaugh et al (1987) 
support the possibility of species difference. 
In the chronic salt loading experiment (i.e. one 
year), the Na+,K+-ATPase activity of the heart, skeleta l 
muscle, renal medulla and aorta were found to be increased 
(Figs. 8.6. to 8.10.). This fi nding of increased Na+,K+-
ATPase activity after chronic salt loading agrees well 
with previous reports. Wald et al (1983) demonstrated 
increased renal Na+,K+-ATPase activity in rats given a 
high salt diet for 12 days. Swann (1985) showed that 
chronic(l month) high salt diet increased the 
ATPase activity and ouabain binding in the renal medulla 
in rats. Wauquier et al (1986) studied the effects of 
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h i h odi um di e t a nd DLS activ ity in r a t .=> a n d -o u ( (j 
o mp nsatory increase i n p ump a ct i v ity i n the e r y t h ro c y r >;..; 
a ft e r 3 mon ths of salt loading. Overbeck e t al ( 19 8 2 b) 
also fo und an increased ouabain-sensitive 8 6Rb upt a k e I n 
t h e arterial tissues from rats wi th DOCA-salt 
h ypertension. 
The present findings suggest that there i s an 
adaptive increase in pump activity after chronic s alt 
l oading and is likely to be a compensatory response to the 
chron i c inh i bition of the sodium pump by the NH i n vivo. 
Du r i ng chronic salt loading, the level of NH (and t h us it s 
i nh i b iti on) is increased (Wauquier & Devynck 1 989 ). 
Consequently, there is a rise in the intracellular Na + a n d 
the ce ll response to this by an increase in the Na + , K+ -
ATP ase ac t i v ity. In this respect, extensive studies o f 
the re l at i onship between intracellular sodium content a n d 
p u mp acti v ity in both tissue preparations and ce ll 
c ult ures ind i cate that the increase in Na+,K+-ATPase 
ac tivi t y i s due to de no v o synt h esis of pump s it es 
( Overbeck & Grissette 1 982ai Chapter 3). When t issues are 
removed, processed and 
rapidly dissoc i ate from 
studied in vi tro, the NH ma y 
the newly-rat tissues. Thus 
synthesised active pump molecules on the plasma membrane 
in the tissues are then seen as increased pump activity in 
vi tro . This hypothesis is supported by the study of Swann 
(1985), who found an increase in Na+,K+-ATPase activi t y 
accompanied by a significant increase in 3H-ou abain 
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b i nd i ng ( a me a s u r e o f pump numbe r) i n the r e nal me du ll ~ e f 
r ts gi v e n 5% NaC l diet f or 4 week s . 
The pre s e nt study is thus consi s t e nt with pre v iou 
r e ports and suggests that chronic salt loading r esults i n 
an adaptive increase in Na+,K+-ATPase activity in the 
vascular and other tissues. 
In the present study, it was noted that a significant 
increase in renal Na+,K+-ATPase has already been observed 
after 7 days of salt loading. This result suggests tha t 
an adaptive response to salt loading occurs much more 
quickly in the kidney than in other tissues. It also 
concurs with previous findings of Wald et al (1983) and 
Swann (1985 ) , who demonstrated an increased Na+,K+-ATPase 
acti v ity of the renal medulla in rats after 1 to 4 wee k s 
of sa l t loading . The exact explanation for such a rapid 
response is lacking, but there are several possible 
reasons. Firstly, it may be due to the difference in t he 
dissociat i on rates of the NH-Na+,K+-ATPase complexes among 
different tissues. Tobian e t al (1972) and Erdmann and 
Schoner (1972) found that different tissues (e.g. heart, 
brain, kidney) of the same species (e.g. cow, guinea pigs) 
have different rates of dissociation of their respective 
digitalis-enzyme complexes. Erdmann (1981) further 
demonstrated that the kidney has the highest rate of 
dissociation (Kd = 10 uM) when compared to the brain (Kd = 
16nM) and skeletal muscle (Kd = 12SnM). Therefore, i t ma y 
be the easiest and fastest for the NH-Na+ ,K+-ATPase 
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comp l x s to b e c ompl e t e ly d is s o ciate d in t he r at k i dn e y. 
The k idn e y may thus be the fir s t o rga n to s u ff e r fr m 
s u bma ximal inhibition of the sodium pump by the pu tat i v _ 
NH, which has been previously demonstrated to r esult in a 
compensatory increase in the sodium pump activity ( Section 
3.6.2) . This hypothesis was also suggested by Swann 
(1985) to explain for the compensatory increase found i n 
Na+,K+-ATPase activity in the renal medulla but not in t h e 
brain or skeletal muscle. Furthermore, it is also 
possible that different tissues have different rates of de 
novo synthesis of sodium pump sites. This explanation is 
supported by the findings that the renal Na+,K+-ATPase 
mRNA is processed and/or transported at a higher rate than 
hepatic Na+,K+-ATPase mRNA in the biosynthesis of subunits 
of Na + , K+-ATPase (Gick, Beigi & Edelman 1988). As 
Na + , K+ - ATPase in the different tissues perform different 
specialised physiological functions (e.g. in the kidney, 
the enzyme is responsible for sodium and water 
reabsorption; in the neuromuscular tissues, it maintains 
the electrochemical gradient across the cell membrane), it 
is conceivable that the fulfilment of these specialised 
tasks may require the enzyme to exhibit subtle differences 
in its rate of turnover and sensitivity to stimuli 
regulating its activity. 
Another explanation for the rapid response of the 
renal Na+,K+-ATPase to salt loading is that the kidney ma y 
well be the target organ for the putative NH. It is 
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11 r lly gr d tha t the p a thoge nes i s of 0 It - indu c(~ ( 
hyperte n s ion involv e s a primary d efect of r n al . Cil 
e xcre tion. High salt intake will lead to ECFV exp a n sion 
and increase the level of circulating NH (Section 2. 3. a nd 
Sect ion 2.4.). The principal action of NH is to promote 
sodium excretion by inhibiting the renal Na+,K+-ATPase s o 
that the body sodium and fluid balance returns to norma l . 
It is speculated that the renal Na+,K+-ATPase lS more 
sensitive to the action of NH than other tissue Na+ K+-, 
ATPase. This hypothesis is supported by an earlier report 
of Wald et al (1983), who found a significantly increased 
filtered sodium load with a quick adaptive increase in 
renal Na+,K+-ATPase to plasma NH in rats after 12 days of 
salt loading. Favre et al (1975) and Gonick and Saldanha 
( 1975) showed that the action of NH on Na+,K+-ATPase 
activity in the cardiovascular tissues apparently requires 
a longer period and higher concentration than its action 
on renal Na + , K+ -ATPase, since intravenous or intraaortic 
injection of urine extracts containing the putative NH 
into rats quickly produces natriuresis without a 
simultaneous change in the blood pressure. Thus, when 
rats were chronically salt-loaded, the renal tubular 
Na+,K+-ATPase may be the first to respond to the enhanced 
sodium delivery to the nephrons and to the increasing 
level of NH; natriuresis promptly results. Subsequently, 
renal Na +, K+ -ATPase shows an adaptive increase in enzyme 
activity in response to the chronic presence of increasing 
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1 v 1 0 f N H . S u c h 1 0 n g - t e rrn r e g u 1 a t i o n 0 f r e n 1 l[ -1 + I 1< t-
ATP probably r es ult s f rom the s yn t hes i s of n e 1d \ rnp 
site s, a s suggested by previous worke r s (Katz & Ep ...... t ei n 
1967 ) . 
Hepatic Na+,K+-ATPase increased after 3 month s of 
salt loading in rats. The effect of salt loading o n 
hepatic Na+, K+ -ATPase has not been previously studied. 
The time course of this increase agrees with that of 
Lindsay and Parker (1976), who demonstrated a significant 
increase in hepatic Na+ ,K+ -ATPase activity in rats after 
45 days of digoxin treatment. 
It is important to note that aortic Na+,K+-ATPase, as 
reasoned above, showed an adaptive increase in enzyme 
This acti v it y after chronic salt loading in Experiment 3. 
is in agreement with that of Vasdev et al (1988), who 
found that chronic high salt diet increased the vascular 
86 Rb uptake (a measure of pump activity) in both Dahl-
sensitive and Dahl-resistant rats. They further suggested 
t h at the increased pump activity could be due to an 
increase in the density of pump sites on the cell membrane 
from de novo synthesis. The present finding also suggests 
that the adaptive mechanism, probably due to de novo 
synthesis of new pump sites, 
than that in the renal and 
is slower in vascular tissues 
hepatic tissues. If NH is 
induced in vivo by the present salt loading protocols, the 
inhibitory effect of NH on vascular Na+,K+-ATPase does not 
persist. 
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On ma y argu e th a t the ob se rv e d i n cr a I n t (~ 
+ + Na ,K -ATPas e activity of the variou s ti ss ues after 1 -
loading may be due to a decrease in protein content o f 
tissues. In light of previous work on the effect o f 
malnutrition on Na+,K+-ATPase activity, this is very 
unlikely. Turaihi et al (1988) found that patients with 
anorexia nervosa had a significantly lower 86 Rb uptake and 
3H- OBS in leucocytes. Pasquali et al (1988) also found 
that the Na+,K+-ATPase activity of erythrocytes of persons 
with hypocaloric feeding was significantly lower. Weight 
loss was found to be associated with a decreased 3H- OBS 
and ouabain-sensitive Rb influx in leucocytes (Baron et al 
1987 ) . These findings suggest that weight loss or 
malnutrition should be associated with a decreased sodium 
pump activity. 
In summary, the present findings show that there is 
an adaptive increase in the Na + ,K+ -ATPase acti vi ty after 
chronic salt-loading. This suggests that the sodium pumps 
may not be persistently inhibited by the putative 
endogenous natriuretic hormone induced by salt loading. 
De novo synthesis of new pump sites after chronic 
inhibition of the pump found by previous workers could 
account for this adaptive increase in Na+,K+-ATPase 
activity of tissues . 
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---HA TER CONCLUSION AND FUTURE WORK 
A c i rculating humoral digitalis- l ike inh i b itor of h 
Na+ ,K+-ATPase has b e en implicated in the p athoge nesi s of 
hypertension (Section 2.3). Its extra-renal i n hibit ion 
of vascular Na+,K+-ATPase has been suggested to inc rease 
smooth muscle contractility, enhance sympathetic dr ive 
and cause an elevation of blood pressure (Section 2.3. ) . 
The aim of this work was to study the changes in 
Na + , K+-ATPase activity of various tissues after acute a nd 
c hron i c administrat i on of digoxin and salt loading. 
In the first series of digox i n experiments I s hort-
t e rm t reatment of d i goxin for 3 days and 7 days resu l ted 
in a s ign if icant inhibi tion of Na + I K+ -ATPase of all t h e 
ti ssues studied . These results were compatible wit h t h e 
we ll -established inhibitory action of digoxin on Na+, K+ -
ATPase, and confirmed the adequacy of the digoxin regimes. 
On chronic digoxin treatment (i. e. 3 months), howe ver I 
s uch inhib i t i on of the sodium pump was not observed in a ll 
t he tissues studied except in the vascular smooth muscle. 
These findings indicate that the inhibitory effect of 
digoxin on 
i nhibition 
Na+,K+-ATPase does not 
of Na+,K+-ATPase may 
regeneration of sodium pump sites. 
persist and chronic 
elicit an adaptive 
These findings conf irmed those of previous workers 
using cell cultures and tissue homogenates that chronic 
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inhibition of the s odium pump result s In a corn 
increase in its activity due to de novo s ynthesis o f n w 
pump sites (Chapter 3). Such an adaptive r esponse wa s not 
observed in the vascular Na+,K+-ATPase after 3 months o f 
digoxin treatment. This suggests that there may be a 
slower rate of synthesis of new pump sites in the vascular 
tissue. 
In a second series of experiments, the temporal 
effect of salt loading on Na+,K+-ATPase activity was 
examined. Existing evidence suggest the presence of a 
circulating EDLS in rats after acute and chronic salt 
loading (Gonick et al 1977; Devynck et al 1984a & b· I 
Wauquier & Devynck 1989). The present results showed that 
after 1 week and 3 months of salt loading, the inhibitory 
effect of the EDLS on Na + ,K+ -ATPase was not evident in 
vitro in all the tissues studied. This may be due to an 
inadequate level of NH being induced or more likely be due 
to the dissociation of NH from the pump sites during 
experimenta l manipulation. In chronic salt loading (i.e. 
1 year), an adaptive increase in tissue Na+,K+-ATPase 
activity was observed in all the tissues studied. These 
results are consistent with those of the digoxin 
experiments and suggest that chronic inhibition of Na+,K+-
ATPase results in an adaptive or compensatory response. 
It was noted that there were certain differences in 
the time of onset of the adaptive change in the Na+ I K+-
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ATP b t\.J n t h e d igo xi n a nd sa l t 10 ding x · l rrt . O c· 
I n the c a rd i ac a nd skel e tal mu s cle , after 3 mon h ~ o f 
d i goxin treatme nt, there was a comp e n sa tory r espon se I n 
the Na+,K+-ATPase activity; however, in the sa l t loading 
experiments, such a response was not observed af ter 3 
months. This may be due to a difference in the level (and 
thus the degree of activity) of the inhibitor. The pl asma 
digoxin levels were maintained at high concentrations 
( 3.S-4ng/ ml ), which was considered in the toxic range in 
the h umans, in the three digoxin experiments. Th is h igh 
level of inhibitor implied a greater magnit u de of 
inhibition of the pump at an early stage resulting in a n 
ear lier rise of intracellular Na+ and subsequent cel lular 
regu l a ti o n of pump activi t y. In the sa lt l oad i ng 
exper ime nt s, the plasma EDLS levels were not measured b ut 
had previousl y been shown to rise graduall y with time 
the l e v e l of NH induced after 3 mont h s of salt l oading was 
compara ti vely low and was 71.S±8.2 pg / ml(mean±SD ) 
(Wa uqu i er & Devyn c k 1989) Thus, it is specu l ated that a 
greater degree of inhibition of Na+,K+-ATPase act iv ity i n 
the digoxin experiments explains the earlier onset of t h e 
adaptive response of Na+ ,K+-ATPase in the heart and 
skeletal muscle. 
In the digoxin experiments, the hepatic Na+,K+-ATPas e 
showed an adaptive response after 3 months of digox in 
inhibition. This is compatible with the observed i nc r e as e 
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i n th h patic s odi um pump a ctivity aft e r 3 month ~ f ~ (l _ 
10 di ng o 
An adaptive increase in th e r e n a l + + Na , K -A TP a ...J 
activity was observed after 7 days of salt loa d i n g . Suc h 
a response occurred after 3 months of digoxin inhib i t ion . 
The discrepancy may be explained by the difference in the 
sensitivity of the renal Na+,K+-ATPase to the t wo 
inhibitors. Being a cardiac glycoside, digoxin acts 
primarily on the cardiac Na+,K+-ATPase (by inhibition) to 
exh ibit its inotropic effects (Schwartz 1976). The renal 
sodium pump may be less sensitive to the inhibition of 
digoxin than the cardiac pump. It has been shown that 
injection of plasma extracts containing NH from salt-
l oaded rats immediately resulted in natriuresis (Gonick 
and Saldanha 1975; Favre et al 1975). This supports t h e 
hypothesis that renal tubular Na+, K+ -ATPase is very 
sensiti v e to the inhibitory effect of NH. The fact that 
ouabain has little natriuretic effect further confirms 
t hat renal Na+,K+-ATPase is more sensitive to the action 
of NH than to that of digoxin. Hence, the renal Na+,K+-
ATPase may respond faster and to a lower concentration of 
NH than to digoxin. This explains why an adaptive 
increase in renal Na+,K+-ATPase was obtained much earlier 
in the salt loading experiments. Such a quick 
compensatory increase in renal Na+,K+-ATPase has been 
previously reported (Wald et al 1983, 1985a). 
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I n th e prese nt chronic dig oxin e xp erim e nt ~ , d 
c ompe nsa tory response of Na+,K+ - ATPase was obs e rve d i n 11 
the tissues except in the aorta, a s d iscus se d i n 
Section 7.4. This finding suggests a slower r a t e of d e 
novo synthesis of pump sites in the aorta such that the 
vascular sodium pump may take a longer time (i. e. more 
than 3 months) to reveal the compensatory response to 
chronic inhibition. This suggestion is supported by the 
finding of an adaptive increase in Na+,K+-ATPase activity 
of the aorta in rats after one year of salt loading. 
Therefore, the present findings suggest that chronic 
submaxima1 inhibition of Na+,K+-ATPase in the various 
tissues including the vascular tissues may resul t in an 
adaptive regeneration of pump activity. 
There are certain areas in the present study which 
warrant further clarification. It has been presumed that 
the present salt loading protocols were effective to 
induce the release of endogenous NH. The measurement of 
plasma EDLS and renin activity should be included in 
future sal t loading experiments to conf inn the presence 
and action of the NH. 
It has been reasoned that the adaptive increase in 
Na+,K+-ATPase activities of various tissues of rats after 
chronic salt-loading was due to the effect of putative NH. 
To date, as the evidence for the existence of NH remains 
circumstantial, it remains to be seen whether such adaptive 
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r p n \.Jas du e t o NH per se o r d ue to oth r n t i u _(.: j . 
f c t o r s (such as dop a min e and ANP ) o r in t e r act ' nr 
me cha nisms. As described in Section 2.4.4, a high s od i um 
diet cause increased dopamine excretion and plasma l e vel 
of ANP. A high dietary sodium intake has al s o been 
reported to activate pressor response to exogen eous 
noradrenaline and angiotensin (Cowley and Lohmeier,1979), 
increased level of plasma noradrenaline and number of 
vascular angiotensin 11 receptors (Catt et al,1984). It 
is not known whether these natriuretic factors and/or 
physiologic response(s) interact with the putative NH to 
affect the Na+/K+-ATPase activities in rats after chronic 
salt loading. 
The quantitation of sodium pump concentration using 
3H-ouabain can be performed together with the measurement 
of Na+,K+-ATPase activity in order to provide more 
understanding of the adaptive response of the pump to 
chronic inhibition. In fact, preliminary 3H-ouabain 
binding experiments had been carried out on crude 
homogenates of the aorta and renal tissue in which some 
difficulties were encountered. The ouabain-enzyme 
complexes rapidly dissociated during the filtration step 
required for separating bound and free ouabain. The high 
nonspecific binding masked the low specific binding of 
ouabain in the vascular tissue. These problems were also 
reported by other workers (Lin & Akera, 1978). Norgaard 
(1986) proposed the measurement of the sodium pump en z yme 
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ti v ity by t h 3 - 0 - MFP ase assa y to qu a n it - e 
n c nt r t i on o f pump sites . It has bee n s hown t h t th _ ~ -
O- MFPase activity correlated well wit h th e 3H- ou abain 
binding in crude homogenates of the rat s keletal mu scl 
(Norgaard et al 1984). 
This is the first report on the measurement of the 
enzyme activity of the sodium pump in aorta, using the 3-
O-MFPase assay. + + Most previous studies on Na ,K -ATPase in 
various tissues of laboratory animals were based on the 
membrane fractions of the enzyme which comprised less than 
a few percent of the total enzyme activity available in 
the starting material. It is not known whether these 
fractions represent a genuine random sample of the plasma 
membrane or in fact are localized or subspecialised 
regions thereof. This poses a serious disadvantage to the 
quantitation of the changes in the total Na+,K+-ATPase 
concentration under various experimental conditions. The 
isolation of the membrane preparations inevitably leads to 
l ow recovery of Na+,K+-ATPase and this raises a problem in 
measuring very + ...!.. low Na ,K ' -ATPase activity in certain 
tissues (e.g. VSMC, platelets). In the present study, the 
3-0-MFPase assay was shown to be applicable in measuring 
the low Na + ,K+ -ATPase acti vi ty in the vascular tissue. 
Further improvement on this method will help future study 
on the sodium pump in the vascular tissue. 
The present findings suggest that there may be some 
subtle difference in the biophysical properties of t he 
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s odium pump a mong di ffere nt 
synthesis of pump sites, 




e . g. in h 
sensitivity 
sodium pump 
t o pumf 
i n th 
vascular tissue rather than in other tissues should b e 
more elucidative in the study of the pathogenesi s of 
hypertension. 
In future experiments, the in vivo Rb uptake method 
should be used for the measurement of Na + I K+ -ATPase 
activity in the rats given digoxin and salt loading 
regimes. This would eliminate the possible dissociation 
of the inhibitor during in vitro manipulations. 
In summary, the present study suggests that chronic 
inhibition of the sodium pump elicits an adaptive 
regeneration of the Na+,K+-ATPase activity. 
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